{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "6d0db0aa",
   "metadata": {},
   "source": [
    "# Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "baec4770",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2023-06-14 01:10:23.034061: I tensorflow/tsl/cuda/cudart_stub.cc:28] Could not find cuda drivers on your machine, GPU will not be used.\n",
      "2023-06-14 01:10:23.673976: I tensorflow/tsl/cuda/cudart_stub.cc:28] Could not find cuda drivers on your machine, GPU will not be used.\n",
      "2023-06-14 01:10:23.675264: I tensorflow/core/platform/cpu_feature_guard.cc:182] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n",
      "To enable the following instructions: AVX2 FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n",
      "2023-06-14 01:10:29.657853: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Could not find TensorRT\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import tensorflow as tf\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import zipfile as zf\n",
    "from glob import glob\n",
    "# from keras.saving.hdf5_format import save_attributes_to_hdf5_group\n",
    "from transformers import T5Tokenizer, TFT5Model, TFT5ForConditionalGeneration, AutoTokenizer, TFBertModel, AutoModel, BertTokenizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b398d7ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2023-06-14 01:10:54 w210-therapeutic-accelerator metapub.config[18022] WARNING NCBI_API_KEY was not set.\n"
     ]
    }
   ],
   "source": [
    "# !pip install semanticscholar\n",
    "# !pip install metapub\n",
    "# !pip install sentencepiece\n",
    "import sentencepiece\n",
    "from metapub import PubMedFetcher\n",
    "from semanticscholar import SemanticScholar\n",
    "from metapub import FindIt\n",
    "import requests\n",
    "import urllib\n",
    "import json"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d65d39ce",
   "metadata": {},
   "source": [
    "## Tokenizer & Model Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "304645fa",
   "metadata": {},
   "outputs": [],
   "source": [
    "bio_bert_model = AutoModel.from_pretrained(\"gsarti/biobert-nli\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "38172587",
   "metadata": {},
   "outputs": [],
   "source": [
    "bio_bert_tokenizer = AutoTokenizer.from_pretrained(\"gsarti/biobert-nli\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "ee271843",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "All PyTorch model weights were used when initializing TFT5ForConditionalGeneration.\n",
      "\n",
      "All the weights of TFT5ForConditionalGeneration were initialized from the PyTorch model.\n",
      "If your task is similar to the task the model of the checkpoint was trained on, you can already use TFT5ForConditionalGeneration for predictions without further training.\n"
     ]
    }
   ],
   "source": [
    "original_bert_tokenizer = BertTokenizer.from_pretrained('bert-base-uncased')\n",
    "T5Abstract_model = TFT5ForConditionalGeneration.from_pretrained('t5-base')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "6205b715",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/brathwaiten16_berkeley_edu/anaconda3/lib/python3.10/site-packages/transformers/models/t5/tokenization_t5.py:163: FutureWarning: This tokenizer was incorrectly instantiated with a model max length of 512 which will be corrected in Transformers v5.\n",
      "For now, this behavior is kept to avoid breaking backwards compatibility when padding/encoding with `truncation is True`.\n",
      "- Be aware that you SHOULD NOT rely on t5-base automatically truncating your input to 512 when padding/encoding.\n",
      "- If you want to encode/pad to sequences longer than 512 you can either instantiate this tokenizer with `model_max_length` or pass `max_length` when encoding/padding.\n",
      "- To avoid this warning, please instantiate this tokenizer with `model_max_length` set to your preferred value.\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "T5tokens = T5Tokenizer.from_pretrained('t5-base')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "11181285",
   "metadata": {},
   "source": [
    "## Data Import"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "ea63fb1d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# !gunzip ../zip_file1.gz"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "8a9038c3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Get info about the latest release\n",
    "latest_release = requests.get(\"http://api.semanticscholar.org/datasets/v1/release/2023-05-30\", \n",
    "                              headers={'x-api-key':'jvN8XitMY59Wtoqm3FZnc94qRHnsKw3z3hLNh7XB'}).json()\n",
    "\n",
    "# Get info about past releases\n",
    "dataset_ids = requests.get(\"http://api.semanticscholar.org/datasets/v1/release\").json()\n",
    "earliest_release = requests.get(f\"http://api.semanticscholar.org/datasets/v1/release/{dataset_ids[0]}\").json()\n",
    "\n",
    "# Get info about the papers dataset\n",
    "papers = requests.get(\"http://api.semanticscholar.org/datasets/v1/release/latest/dataset/papers\",\n",
    "                      headers={'x-api-key':'jvN8XitMY59Wtoqm3FZnc94qRHnsKw3z3hLNh7XB'}).json()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "1372be80",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      " \"name\": \"s2orc\",\n",
      " \"description\": \"Full-body paper text parsed from open-access PDFs. Identifies structural elements such as paragraphs, sections, and bibliography entries.\\n5M records in 30 4GB files.\",\n",
      " \"README\": \"Semantic Scholar Academic Graph Datasets\\n\\nThe \\\"s2orc\\\" dataset contains parsed full-body text from selected papers.\\n\\nA subset of this data was previously released (in a different format) as S2ORC https://github.com/allenai/s2orc\\n\\nThe body text is parsed from PDF documents using Grobid, documented at https://grobid.readthedocs.io.\\nIts output is converted from XML into a single string with a set of annotation spans.\\n\\nSCHEMA\\n - externalIds: IDs of this paper in different catalogs\\n - content:\\n   - source:\\n\\t   - pdfUrls: URLs to the PDF\\n\\t   - oaInfo: license/url/status information from Unpaywall\\n   - text: Full body text as a single string\\n   - annotations: Annotated spans of the full body text\\n\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\n@inproceedings{lo-wang-2020-s2orc,\\n    title = \\\"{S}2{ORC}: The Semantic Scholar Open Research Corpus\\\",\\n    author = \\\"Lo, Kyle  and Wang, Lucy Lu  and Neumann, Mark  and Kinney, Rodney  and Weld, Daniel\\\",\\n    booktitle = \\\"Proceedings of the 58th Annual Meeting of the Association for Computational Linguistics\\\",\\n    month = jul,\\n    year = \\\"2020\\\",\\n    address = \\\"Online\\\",\\n    publisher = \\\"Association for Computational Linguistics\\\",\\n    url = \\\"https://www.aclweb.org/anthology/2020.acl-main.447\\\",\\n    doi = \\\"10.18653/v1/2020.acl-main.447\\\",\\n    pages = \\\"4969--4983\\\"\\n}\\n\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "print(json.dumps(latest_release['datasets'][7], indent=1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "4acff6d8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'release_id': '2022-05-10',\n",
       " 'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThese datasets provide a variety of information about research papers taken from a snapshot in time of the Semantic Scholar corpus.\\n\\nThis site is provided by The Allen Institute for Artificial Intelligence (“AI2”) as a service to the\\nresearch community. The site is covered by AI2 Terms of Use and Privacy Policy. AI2 does not claim\\nownership of any materials on this site unless specifically identified. AI2 does not exercise editorial\\ncontrol over the contents of this site. AI2 respects the intellectual property rights of others. If\\nyou believe your copyright or trademark is being infringed by something on this site, please follow\\nthe \"DMCA Notice\" process set out in the Terms of Use (https://allenai.org/terms).\\n\\nSAMPLE DATA ACCESS\\nSample data files can be downloaded with the following UNIX command:\\n\\nfor f in $(curl https://s3-us-west-2.amazonaws.com/ai2-s2ag/samples/MANIFEST.txt)\\n  do curl --create-dirs \"https://s3-us-west-2.amazonaws.com/ai2-s2ag/$f\" -o $f\\ndone\\n\\nFULL DATA ACCESS\\nDownloading the full data requires an API key, which can be obtained at https://www.semanticscholar.org/product/api#Partner-Form\\nFor access to the full datasets, see https://api.semanticscholar.org/api-docs/datasets.\\n\\nLICENSE and ATTRIBUTION\\n\\nSee the README files for each dataset for information about licensing and attribution.',\n",
       " 'datasets': [{'name': 'abstracts',\n",
       "   'description': 'Paper abstract text, where available.\\n100M records in 30 1.8GB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"abstracts\" dataset provides abstract text for selected papers.\\n\\nSCHEMA\\n - openAccessInfo\\n   - externalIds: IDs of this paper in different catalogs\\n   - license/url/status: open-access information provided by Unpaywall, linked by DOI or PubMed Central ID\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@inproceedings{Ammar2018ConstructionOT,\\n  title={Construction of the Literature Graph in Semantic Scholar},\\n  author={Waleed Ammar and Dirk Groeneveld and Chandra Bhagavatula and Iz Beltagy and Miles Crawford and Doug Downey and Jason Dunkelberger and Ahmed Elgohary and Sergey Feldman and Vu A. Ha and Rodney Michael Kinney and Sebastian Kohlmeier and Kyle Lo and Tyler C. Murray and Hsu-Han Ooi and Matthew E. Peters and Joanna L. Power and Sam Skjonsberg and Lucy Lu Wang and Christopher Wilhelm and Zheng Yuan and Madeleine van Zuylen and Oren Etzioni},\\n  booktitle={NAACL},\\n  year={2018}\\n}\\n'},\n",
       "  {'name': 'authors',\n",
       "   'description': 'The core attributes of an author (name, affiliation, paper count, etc.). Authors have an \"authorId\" field, which can be joined to the \"authorId\" field of the members of a paper\\'s \"authors\" field.\\n75M records in 30 100MB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"authors\" dataset provides summary information about authors.\\n\\nSCHEMA\\nSee https://api.semanticscholar.org/api-docs/graph#tag/Author-Data\\n\\nThis dataset does not contain information about an author\\'s papers.\\nInstead, join with authors.authorId from the \"papers\" dataset.\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@inproceedings{Ammar2018ConstructionOT,\\n  title={Construction of the Literature Graph in Semantic Scholar},\\n  author={Waleed Ammar and Dirk Groeneveld and Chandra Bhagavatula and Iz Beltagy and Miles Crawford and Doug Downey and Jason Dunkelberger and Ahmed Elgohary and Sergey Feldman and Vu A. Ha and Rodney Michael Kinney and Sebastian Kohlmeier and Kyle Lo and Tyler C. Murray and Hsu-Han Ooi and Matthew E. Peters and Joanna L. Power and Sam Skjonsberg and Lucy Lu Wang and Christopher Wilhelm and Zheng Yuan and Madeleine van Zuylen and Oren Etzioni},\\n  booktitle={NAACL},\\n  year={2018}\\n}\\n'},\n",
       "  {'name': 'citations',\n",
       "   'description': 'Instances where the bibliography of one paper (the \"citingPaper\") mentions another paper (the \"citedPaper\"), where both papers are identified by the \"paperId\" field. Citations have attributes of their own, (influential classification, intent classification, and citation context).\\n2.4B records in 30 8.5GB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"citations\" dataset provides details about one paper\\'s citation of another paper.\\n\\nSCHEMA\\n - isinfluential: true/false if the citation is considered influential. https://www.semanticscholar.org/faq#influential-citations\\n - contexts: Text surrounding the citation in the source paper\\'s body.\\n - intents: Classification of the intent behind the citations. https://www.semanticscholar.org/faq#citation-intent\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@inproceedings{Ammar2018ConstructionOT,\\n  title={Construction of the Literature Graph in Semantic Scholar},\\n  author={Waleed Ammar and Dirk Groeneveld and Chandra Bhagavatula and Iz Beltagy and Miles Crawford and Doug Downey and Jason Dunkelberger and Ahmed Elgohary and Sergey Feldman and Vu A. Ha and Rodney Michael Kinney and Sebastian Kohlmeier and Kyle Lo and Tyler C. Murray and Hsu-Han Ooi and Matthew E. Peters and Joanna L. Power and Sam Skjonsberg and Lucy Lu Wang and Christopher Wilhelm and Zheng Yuan and Madeleine van Zuylen and Oren Etzioni},\\n  booktitle={NAACL},\\n  year={2018}\\n}\\n\\n@inproceedings{cohan-etal-2019-structural,\\n    title = \"Structural Scaffolds for Citation Intent Classification in Scientific Publications\",\\n    author = \"Cohan, Arman  and\\n      Ammar, Waleed  and\\n      van Zuylen, Madeleine  and\\n      Cady, Field\",\\n    booktitle = \"NAACL\",\\n    year = \"2019\",\\n    url = \"https://aclanthology.org/N19-1361\",\\n    doi = \"10.18653/v1/N19-1361\"\\n}'},\n",
       "  {'name': 'embeddings',\n",
       "   'description': 'A dense vector embedding representing the contents of the paper.\\n120M records in 30 28GB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"embeddings\" dataset provides embeddings representing a paper\\'s contents in vector form.\\n\\nThe model is based on the SPECTER model available at https://github.com/allenai/specter. However, the embeddings\\nincluded in this dataset are not compatible with the embeddings produced by the pretrained model from that repo.\\n\\nLICENSE\\nThis software is released under the Apache 2.0 license. (https://www.apache.org/licenses/LICENSE-2.0)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@inproceedings{specter2020cohan,\\n  title={{SPECTER: Document-level Representation Learning using Citation-informed Transformers}},\\n  author={Arman Cohan and Sergey Feldman and Iz Beltagy and Doug Downey and Daniel S. Weld},\\n  booktitle={ACL},\\n  year={2020}\\n}\\n\\n'},\n",
       "  {'name': 'papers',\n",
       "   'description': 'The core attributes of a paper (title, authors, date, etc.).\\n200M records in 30 1.5GB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"papers\" dataset provides core metadata about papers.\\n\\nSCHEMA\\nSee https://api.semanticscholar.org/api-docs/graph#tag/Paper-Data\\n\\nThis dataset does not contain information about a paper\\'s references or citations.\\nInstead, join with citingPaperId/citedPaperId from the \"citations\" dataset.\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@inproceedings{Ammar2018ConstructionOT,\\n  title={Construction of the Literature Graph in Semantic Scholar},\\n  author={Waleed Ammar and Dirk Groeneveld and Chandra Bhagavatula and Iz Beltagy and Miles Crawford and Doug Downey and Jason Dunkelberger and Ahmed Elgohary and Sergey Feldman and Vu A. Ha and Rodney Michael Kinney and Sebastian Kohlmeier and Kyle Lo and Tyler C. Murray and Hsu-Han Ooi and Matthew E. Peters and Joanna L. Power and Sam Skjonsberg and Lucy Lu Wang and Christopher Wilhelm and Zheng Yuan and Madeleine van Zuylen and Oren Etzioni},\\n  booktitle={NAACL},\\n  year={2018}\\n}\\n\\n\\n'},\n",
       "  {'name': 's2orc',\n",
       "   'description': 'Full-body paper text parsed from open-access PDFs. Identifies structural elements such as paragraphs, sections, and bibliography entries.\\n35M records in 30 3GB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"s2orc\" dataset contains parsed full-body text from selected papers.\\n\\nA subset of this data was previously released (in a different format) as S2ORC https://github.com/allenai/s2orc\\n\\nThe body text is parsed from PDF documents using Grobid, documented at https://grobid.readthedocs.io.\\nIts output is converted from XML into a single string with a set of annotation spans.\\n\\nSCHEMA\\n - externalIds: IDs of this paper in different catalogs\\n - content:\\n   - source:\\n\\t   - pdfUrls: URLs to the PDF\\n\\t   - oaInfo: license/url/status information from Unpaywall\\n   - text: Full body text as a single string\\n   - annotations: Annotated spans of the full body text\\n\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\n@inproceedings{lo-wang-2020-s2orc,\\n    title = \"{S}2{ORC}: The Semantic Scholar Open Research Corpus\",\\n    author = \"Lo, Kyle  and Wang, Lucy Lu  and Neumann, Mark  and Kinney, Rodney  and Weld, Daniel\",\\n    booktitle = \"Proceedings of the 58th Annual Meeting of the Association for Computational Linguistics\",\\n    month = jul,\\n    year = \"2020\",\\n    address = \"Online\",\\n    publisher = \"Association for Computational Linguistics\",\\n    url = \"https://www.aclweb.org/anthology/2020.acl-main.447\",\\n    doi = \"10.18653/v1/2020.acl-main.447\",\\n    pages = \"4969--4983\"\\n}\\n'},\n",
       "  {'name': 'tldrs',\n",
       "   'description': 'A short natural-language summary of the contents of a paper.\\n58M records in 30 200MB files.',\n",
       "   'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"tldrs\" dataset provides short natural-language summaries of a paper\\'s content.\\n\\nThe model is based on the SciTLDR model available at https://github.com/allenai/scitldr.\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@article{cachola2020tldr,\\n  title={{TLDR}: Extreme Summarization of Scientific Documents},\\n  author={Isabel Cachola and Kyle Lo and Arman Cohan and Daniel S. Weld},\\n  journal={arXiv:2004.15011},\\n  year={2020},\\n}\\n\\n\\n'}]}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "earliest_release"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "3e02a521",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'name': 'papers',\n",
       " 'description': 'The core attributes of a paper (title, authors, date, etc.).\\n200M records in 30 1.5GB files.',\n",
       " 'README': 'Semantic Scholar Academic Graph Datasets\\n\\nThe \"papers\" dataset provides core metadata about papers.\\n\\nSCHEMA\\nSee https://api.semanticscholar.org/api-docs/graph#tag/Paper-Data\\n\\nThis dataset does not contain information about a paper\\'s references or citations.\\nInstead, join with citingPaperId/citedPaperId from the \"citations\" dataset.\\n\\nLICENSE\\nThis collection is licensed under ODC-BY. (https://opendatacommons.org/licenses/by/1.0/)\\n\\nBy downloading this data you acknowledge that you have read and agreed to all the terms in this license.\\n\\nATTRIBUTION\\nWhen using this data in a product or service, or including data in a redistribution, please cite the following paper:\\n\\nBibTex format:\\n@misc{https://doi.org/10.48550/arxiv.2301.10140,\\n  title = {The Semantic Scholar Open Data Platform},\\n  author = {Kinney, Rodney and Anastasiades, Chloe and Authur, Russell and Beltagy, Iz and Bragg, Jonathan and Buraczynski, Alexandra and Cachola, Isabel and Candra, Stefan and Chandrasekhar, Yoganand and Cohan, Arman and Crawford, Miles and Downey, Doug and Dunkelberger, Jason and Etzioni, Oren and Evans, Rob and Feldman, Sergey and Gorney, Joseph and Graham, David and Hu, Fangzhou and Huff, Regan and King, Daniel and Kohlmeier, Sebastian and Kuehl, Bailey and Langan, Michael and Lin, Daniel and Liu, Haokun and Lo, Kyle and Lochner, Jaron and MacMillan, Kelsey and Murray, Tyler and Newell, Chris and Rao, Smita and Rohatgi, Shaurya and Sayre, Paul and Shen, Zejiang and Singh, Amanpreet and Soldaini, Luca and Subramanian, Shivashankar and Tanaka, Amber and Wade, Alex D. and Wagner, Linda and Wang, Lucy Lu and Wilhelm, Chris and Wu, Caroline and Yang, Jiangjiang and Zamarron, Angele and Van Zuylen, Madeleine and Weld, Daniel S.},\\n  publisher = {arXiv},\\n  year = {2023},\\n  doi = {10.48550/ARXIV.2301.10140},\\n  url = {https://arxiv.org/abs/2301.10140},\\n}\\n\\n\\n',\n",
       " 'files': ['https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_0cadbe3e-d976-4ddd-a419-5338f4bdb9b9.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=oAz%2BUJWJC5m07qeohdu1%2FZHtx8o%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_1cf93f6a-2a54-4761-a6e2-be64df72abfd.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=fQ6VtPhQ48%2FHQSbLdcsBXyEwp8Q%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_277c5193-816a-41df-914a-63ce8739d3db.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=BPbjf0LEZ6ivFic3SvtQU%2BkIYNU%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_2867ec04-ebb0-4c0a-9cca-bab125db6b3a.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=nNnXqkmBEIt3LGUGzd5UKcgSCog%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_3090aa34-c242-40a3-af8f-ddd0a091fd06.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=0azCWDyYiY4i9b8vPEleiYhM0Os%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_34b5fd04-aadf-4596-9d88-04fb2446f3ee.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=GB8kpjkI3fKFiV11NkCdhJZTMfc%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_3dcdac3f-ae5e-40c5-b3aa-839df4c9fcab.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=CeyCiOicVO17EiS5wpkmdhmZGQ4%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_3e82aa4a-c1aa-4a75-8ff8-8187d98a6091.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=GxJUExC3wcfJxg3TsGp%2Bxmr1to0%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_4917e161-6ddb-4063-b531-2feca0882f0b.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=sMVOdTqdBZxWgiU018GVR0P8RRw%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_4fc33ccd-2d0a-4c83-b965-d38b89c6d268.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=5yX90uj4VW9K4UmeXc8komMVjL0%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_637f0c35-6dad-4dfb-89a4-3875709a2a88.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=6EaZeyVgaJrSZe%2FFoO268%2Fzi5IE%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_6c2fdaac-7adc-44a2-8a2d-2b5d541172a2.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=RxccltwwWCpNrOoDsEf7CoEjH8w%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_7b2aeb4e-f79f-483c-a9d0-8599ed706e73.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=686qBLwgKFvOJfmuk6KrQHCe82c%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_7cc7d33c-3d96-420a-ba29-e7c8c28ef3ff.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=qVHJVFE%2B7iFAl0jwIJqSOaD9Mq8%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_820ddc35-8b54-4771-910b-4adf3cee8b6a.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=QDuJWWdEVYFEf6SvNlIubyndsC4%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_8c41e237-6307-432b-aae8-27c632973ee8.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=ZrMHi5aypjwNVMYgEawWNu4MdxI%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_8db7b95f-6567-4e43-aac2-95f8cee8bd3c.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=bZNu5e%2BUeqiRMnfU227JQM2MXtA%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_9741cb71-bb33-42b2-b819-f29858850e2d.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=igBjz1CJXvJZv1ke8PO%2FVvOW5f8%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_977fc923-c650-4771-be0d-6914d4f160ae.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=vw3AAKunV1yOzJvJFzbfGqXkiD0%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_9deef24f-5b21-480c-9bb4-d4d43cbe49bd.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=Z%2Fx1wR9Jsm%2FKb0gMgONnrSQtdy4%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_9e63c07b-b6ce-4a68-a165-29f551468698.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=367Rz0%2BG4OU8EoLOQs%2FxKNFGXTc%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_b627808d-8810-4896-9491-b2511d8f3dca.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=wmCr91viyLNExUEqCDTyLuDVIpw%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_b9ef1a6f-087c-46ff-b70d-98a39a774fb9.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=Pi7RBInNYPyOG7Zy%2BCLuiL91dks%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_bd63a25e-ca42-49b6-94fb-591608243927.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=yj7arYVZ6W6ZAb0bLJbmdAkJDE0%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_c660fbcd-4148-4e9e-adae-ff1140586c59.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=rYtD7BZCr4gcawiGhCorOEPH46Y%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_cf221546-ac15-4639-8baf-098d4796c113.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=eiY95Pu9BvSWIGcCKQGhTX%2B%2BILA%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_dd0a78f8-8507-4c92-8b56-284ca228445c.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=CpOPlVH4OyS99Mh1x3%2B%2Fhi2%2F%2BtI%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_f9a41976-913e-40e1-badd-3e0bb269515e.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=xMWzO37d9bPAXC8kBX5e4iuVFBE%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_fceae11c-9237-4701-b25e-f1adca6c172d.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=srHGlS%2F3h0y9lNrLDpv5r80V3B8%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884',\n",
       "  'https://ai2-s2ag.s3.amazonaws.com/staging/2023-06-06/papers/20230609_070343_00047_bkw4d_ffcd05f8-ff22-4820-93c1-0d004bc650ab.gz?AWSAccessKeyId=ASIA5BJLZJPW5L7QUUF6&Signature=YhAsWk9LdU9GLx%2BAMPE6%2FoLxX2k%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDRhXxyHi%2FzxH140VeYQtbBc7FapOGrVajADdYE%2BJMhpAIhAK0OxuQH%2FWYx2q7ujDACvEEMNsYiU%2FzYJ8PBZyATDsGmKogECPj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMODk2MTI5Mzg3NTAxIgwaqf1O37fCxeQIp3cq3AMGBt6em3m3bGsoSIE1T8zSmqv%2FljeKt%2FIowHcijR4OqsuFGGfQhZJbnhgKbgYtvHtdDVLSN3IFP4iO1azl%2BXgiABAJgTYE7aUp1VZgEvOwCDltydexBKvAAyiu%2F%2BMS3jPwGNY2zbZkwi9IX4VnRh4ikTOW7e8JlJkoBRcUYxOehGMsfEV5TkXpwnxvZxB3wuYwiEN9J0F564hnKJJSuDli%2F85ZvObVNg6xapHzxo93Yn2TkhaPJNaC9pZxvkb1mFlbfNyTutQVAV0NReoSv3sDzr09t4f6JMwkP5pmPfjw4%2BX4jVN9CWp6M%2BpYsVujfcjrLieDU8aDRg7zeoeVtnYa2NaPUhq0PeuvJGL9MIbs8hHXINve%2FMdBueffhwuac759bKX%2Fc9th%2BwwSBSfOJV6FRRJUtlXDW4RCkliKB8AZOi3ZMNg3YiwojftWUDml1pQFKNwL4XL0JLbKrkJd4I4jl9adVwcZJJIckeHSoQUNpCDzXWUbFviR%2FddMQj6kKmAzHqoM7a5k8fkYoHGmR%2F4863wgQvYWwNDMGNbBsosrwM3WMPReJf2JDLzIDPuQON0XJnrmGjAajWx97LjuZYbz%2BbejRxufb8A7N%2B5VUE%2FYg7fUTOR3e%2BRo1dUAoTD27qOkBjqkAZt1p8HJS4IiuDSLtGvexlUh6NDB%2FML5PqfEJRMQ7rIa6yg2Zu0mOYf7J%2B2geAHhZNVNqC2Oq2%2FqO0KZkKtHjjNzQ8Fqymb3r9Hz8TOVBrmUZEe6l5qhjpzfzyB2SVpCQJu8vPMm%2FfBl9OchgZg%2FQFT%2FY40oZTj%2FaAQ%2BxEr2qdjG1A3c8buyMk8levKhlgY3Y7d%2B%2B5K69kSILr9g%2BC5IMYivt6Eq&Expires=1687309884']}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "papers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "3fd39614",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "In spite of many years of work by a multitude of organizations, a clear and simple standard for software engineering and management requirements and a method to assess their applicability to projects of various types and sizes remains elusive. From IEEE to CMMI to NASA's NPR 7150.2, there is no shortage of sources of information providing various types of requirements and standards for software engineering. Even a book on software project management for “dummies” approaches 400 pages. Wading through this information can dizzy the mind of even the most experienced software engineer; the newbie just trying to “do the right thing” will probably give up, open a text editor and start coding. This lack of clarity and simplicity perhaps goes a long way towards explaining why, in spite of this large body of work, there remains such an incredible variability in the knowledge and application of software engineering discipline not only from one organization to the next, but between groups within the same organization, or even between individual developers in the same group! Surely at least the basics of what should be done and why those things should be done can be conveyed in less than a novel-sized volume. There must be some timeless principles that cut across structured and object-oriented techniques, waterfall and agile methods, and CMMI and NASA standards. To properly interpret software engineering requirements and approaches and successfully (and selectively) apply them, one must first understand them at a fundamental level and how they can benefit the project. This paper will make an admittedly bold and brash attempt to boil it all down into something anyone can understand, hopefully resulting in a brief reference — a type of lens through which existing standards can be more practically viewed.\n"
     ]
    }
   ],
   "source": [
    "sch = SemanticScholar()\n",
    "\n",
    "sch = SemanticScholar(api_key='jvN8XitMY59Wtoqm3FZnc94qRHnsKw3z3hLNh7XB')\n",
    "\n",
    "paper = sch.get_paper('d0bc1501ae6f54dd16534e651d90d2aeeeb1cfc1')  #'10.1093/mind/lix.236.433')\n",
    "\n",
    "paper.referenceCount #number of references in this one, can help us create some sort of pagerank type algo\n",
    "paper.citationCount #number of papers that cited this one\n",
    "paper.externalIds \n",
    "text_example = paper.abstract\n",
    "# paper.embedding\n",
    "print(text_example)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "1ba214b4",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"corpusid\":258426684,\"externalids\":{\"arxiv\":\"2305.00178\",\"mag\":null,\"acl\":null,\"pubmed\":null,\"pubmedcentral\":null,\"dblp\":null,\"doi\":\"10.1007/s13163-023-00468-z\"},\"content\":{\"source\":{\"pdfurls\":[\"https://export.arxiv.org/pdf/2305.00178v1.pdf\"],\"pdfsha\":\"2f6878905f3611424e946ba149e3d5f6ab796771\",\"oainfo\":null},\"text\":\"\\nALGEBRAIC VALUATION RING EXTENSIONS AS LIMITS OF COMPLETE INTERSECTION ALGEBRAS\\n29 Apr 2023\\n\\nDorin Popescu \\nALGEBRAIC VALUATION RING EXTENSIONS AS LIMITS OF COMPLETE INTERSECTION ALGEBRAS\\n29 Apr 2023immediate extensionspseudo convergent sequencespseudo limitssmooth morphismscomplete intersection algebras 2020 Mathematics Subject Classification: Primary 13F30Secondary 13A1813F2013B40\\nWe show that an algebraic immediate valuation ring extension of characteristic p > 0 is a filtered union of complete intersection algebras of finite type.\\n\\nIntroduction\\n\\nB. Antieau and R. Datta have recently proven a positive characteristic analogue [1, Theorem 4.1.1] of Zariski's theorem [17]. It says that every perfect valuation ring of characteristic p > 0 is a filtered union of its smooth F p -subalgebras. This result is an application of [14, Theorem 1.2.5] which relies on some results from [2]. Also E. Elmanto and M. Hoyois proved that an absolute integrally closed valuation ring of residue field of characteristic p > 0 is a filtered union of its regular finitely generated Z-subalgebras (see [1,Corollary 4.2.4]). We remind that a filtered direct limit (in other words a filtered colimit) is a limit indexed by a small category that is filtered (see [13, 002V] or [13,04AX]). A filtered union is a filtered direct limit in which all objects are subobjects of the final colimit, so that in particular all the transition arrows are monomorphisms.\\n\\nIt is well known that if the fraction field extension of an immediate extension V ⊂ V ′ is finite and p > 0 then V ′ may fail to be a filtered direct limit of smooth V -algebras as shows [9, Example 3.13] inspired from [6] (see also [9,Remark 6.10]). An inclusion V ⊂ V ′ of valuation rings is an immediate extension if it is local as a map of local rings and induces isomorphisms between the value groups and the residue fields of V and V ′ . After seeing [4, Theorem 6.2] (see also [15], [16]) we understood that in general we should expect that V ′ is a filtered union of its complete intersection V -subalgebras. In the Noetherian case a morphism of rings is a filtered direct limit of smooth algebras iff it is a regular morphism (see [7], [12]).\\n\\nA complete intersection V -algebra essentially of finite type is a local V -algebra of type C/(P ), where C is a localization of a polynomial V -algebra of finite type and P is a regular sequence of elements of C. Theorem 1 stated below says that V ′ is a filtered union of its V -subalgebras of type C/(P ). Since V ′ is local it is enough to say that V ′ is a filtered union of its V -subalgebras of type T h /(P ), T being a polynomial V -algebra of finite type, 0 = h ∈ T and P is a regular sequence of elements of T . Clearly, T h is a smooth V -algebra and in fact it is enough to say that V ′ is a filtered union of its V -subalgebras of type G/(P ), where G is a smooth V -algebra of finite type and P is a regular sequence of elements of G. Conversely, a V -algebra of such type G/(P ) has the form T h /(P ) for some T, h, P using [12,Theorem 2.5]. By abuse we understand by a complete intersection V -algebra of finite type a V -algebra of such type G/(P ), or T h /(P ) which are not assumed to be flat over V .\\n\\nThe goal of this paper is to establish the following theorem.\\n\\nTheorem 1. Let V ′ be an immediate extension of a valuation ring V and K ⊂ K ′ the fraction field extension. If K ′ /K is algebraic then V ′ is a filtered union of its complete intersection V -subalgebras of finite type.\\n\\n\\nAlgebraic immediate extensions of valuation rings\\n\\nAn inclusion V ⊂ V ′ of valuation rings is an immediate extension if it is local as a map of local rings and induces isomorphisms between the value groups and the residue fields of V and V ′ . Let λ be a fixed limit ordinal and v = {v i } i<λ a sequence of elements in V indexed by the ordinals i less than λ.\\nThen v is pseudo convergent if val(v i − v i ′′ ) < val(v i ′ − v i ′′ ) for i < i ′ < i ′′ < λ (see [3], [11]). A pseudo limit of v is an element w ∈ V with val(w − v i ) < val(w − v i ′ ) (that is, val(w − v i ) = val(v i − v i ′ )) for i < i ′ < λ. We say that v is (1) algebraic if some f ∈ V [T ] satisfies val(f (v i )) < val(f (v i ′ )) for large enough i < i ′ < λ; (2) transcendental if each f ∈ V [T ] satisfies val(f (v i )) = val(f (v i ′ )) for large enough i < i ′ < λ.\\nThe following lemma is a variant of Ostrowski ([6, page 371, IV and III], see also [11,(II,4), Lemma 8]). Lemma 2. (Ostrowski) Let β 1 , . . . , β m be any elements of an ordered abelian group G, λ a limit ordinal and let {γ s } s<λ be a well-ordered, monotone increasing set of elements of G, without a last element. Let t 1 , . . . , t m , be distinct integers. Then there exists an ordinal ν < λ such that β i + t i γ s are different for all s > ν. In particular, there exists an integer 1 ≤ r ≤ m such that\\nβ i + t i γ s > β r + t r γ s for all i = r and s > ν.\\nProof. The known proof from the quoted papers gives the second statement even when the integers t i are not necessarily positive. Then apply this statement iteratively to get the first statement.\\n\\nLemma 3. Let V ⊂ V ′ be an immediate extension of valuation rings, K ⊂ K ′ its fraction field extension and (v i ) i<λ an algebraic pseudo convergent sequence in V , which has a pseudo limit x in V ′ , but no pseudo limit in K. Set\\nx i = (x − v i )/(v i+1 − v i ). Let s ∈ N be the minimal degree of the polynomials f ∈ V [Y ] such that val(f (v i )) < val(f (v j )) for large i < j < λ and g ∈ V [Y ] a polynomial with deg g < s. Then there exist d ∈ V \\\\ {0} and u ∈ V [x i ] for some i < λ with g(x) = du and val(u) = 0.\\nProof. In the Taylor expansion 1\\ng(x) = deg g n=0 (D (n) g)(v i ) · (x − v i ) n with D (n) g ∈ V [Y ] the values val((D (n) g)(v i ) · (x − v i ) n ) are pairwise distinct for all n ≤ deg g and every large enough i because val(x − v i ) = val(v i+1 − v i ) increases, deg(D (n) g) < s and so val((D (n) g)(v i ))\\nis constant for all n ≤ deg g and i large (we could also apply Lemma 2). We cannot have val((D (n) g)(v i )·(x−v i ) n ) < val(g(v i )) for some n > 0 and i large because otherwise we get from above that val(g(x)) = val((\\nD (n) g)(v i ) · (x − v i ) n ) increases, which is false. It follows that val((D (n) g)(v i ) · (x − v i ) n ) > val(g(v i ))\\nfor all n > 0 and i large and so\\ng(x) = g(v i ) + deg g n=1 (D (n) g)(v i )(v i+1 − v i ) n x n i ∈ g(v i )(1 + m ′ ∩ V [x i ]),\\nwhich is enough.\\n\\nLemma 4. Let V ⊂ V ′ be an immediate extension of valuation rings, K ⊂ K ′ its fraction field extension and (v i ) i<λ an algebraic pseudo convergent sequence in K, which has a pseudo limit x in V ′ , algebraic over V , but no pseudo limit in K.\\nAssume that h =Irr(x, K) is from V [X]. Then (1) val(h(v i )) < val(h(v j )) for large i < j < λ,(2)\\nif h has minimal degree among the polynomials f ∈ V [X] such that val(f (v i )) < val(f (v j )) for large i < j < λ, then V ′′ = V ′ ∩ K(x) is a filtered union of its complete intersection V -subalgebras.\\n\\nProof. The first part follows from [5, Corollary 5.5]. Now, assume that deg h is minimal among f having the property from (2). As in Lemma 3 we consider (x i ) i<λ and note that for a polynomial g ∈ V [X] of degree < deg h we have g(x) = du for some d ∈ V ⊂ {0} and u ∈ V [x i ] for some i < λ with val(u) = 0. An element of V ′′ has the form g(x)/t for some \\ng ∈ V [X] with deg g < deg h and t ∈ V \\\\ {0} such that val(g(x)) ≥ val(t). It follows that g(x)/t = (d/t)u ∈ V [x i ] m ′ ∩V [x i ] , where m ′ is the maximal ideal of V ′ . Thus V ′′ is the union of (V [x i ] m ′ ∩V [x i ] ) i<λ ,V [x i ] ∼ = V [X i ]/(h i ), where h i is defined below. Set g i = h(v i + (v i+1 − v i )X i ) ∈ V [X i ]. By construction x i = (x − v i )/(v i+1 − v i ) and so g i (x i ) = h(x) = 0. As h is irreducible in K[X] we get g i irreducible in K[X i ] too because it is obtained from h by a linear transformation. So K[x i ] ∼ = K[X i ]/(g i ).\\nWe have g i = uh i for some primitive polynomial h i of V [X i ] and a nonzero constant u of K. Then V ′′ is a filtered union of its complete intersections V -subalgebras.\\n\\nRemark 5. The extension V ⊂ V ′′ from (2) of the above lemma is isomorphic with the one constructed in [3,Theorem 3].\\n\\nNext, we need the following elementary lemma. Lemma 6. Let B be a complete intersection algebra over a ring A and C a complete intersection algebra over B. Then C is a complete intersection algebra over A.\\nProof. Suppose that B ∼ = A[X]/(f ), where X = (X 1 , . . . , X n ) and f = (f 1 , . . . , f r ) is a regular sequence of elements in A[X]. Similarly, C ∼ = B[Y ]/(g), where Y = (Y 1 , . . . , Y m ) and g = (g 1 , . . . , g s ) is a regular sequence of elements in B[Y ]. Since A[X, Y ] is flat over A[X] we see that f is a regular sequence of elements in A[X, Y ]. Note that g i is a residue class modulo f A[X, Y ] of a polynomial G i ∈ A[X, Y ], 1 ≤ i ≤ s.\\nWe claim that f, G form a regular sequence of elements of A[X, Y ]. It is enough to see that G is a regular sequence of elements of\\nA[X, Y ]/(f ) ∼ = B[Y ], which is true by assumption. So, C ∼ = A[X, Y ]/(f, G) is a complete intersection A-algebra.\\nLemma 7. Let V ′ be an immediate extension of a valuation ring V , K ⊂ K ′ their fraction field extension and K ′ = K(x) for some x ∈ V ′ , x ∈ K algebraic over K. Then there exists K 1 ⊂ K ′ , K 1 = K ′ containing K such that x is a pseudo limit of an algebraic pseudo-convergent sequence v = (v j ) j<λ in V 1 = V ′ ∩ K 1 having x as a pseudo limit and for a polynomial h ∈ V 1 [Y ] with minimal degree among the polynomials f ∈ V 1 [Y ] with val(f (v i )) < val(f (v j )) for large i < j < λ there exists no pseudo limit of v in K 1 (h(x)).\\n\\nProof. By [3, Theorem 1] there exists an algebraic pseudo-convergent sequence v = (v j ) j<λ in V having x as a pseudo limit but no pseudo limits in K. Let h ∈ V [Y ] be a polynomial with minimal degree among the polynomials f ∈ V [Y ] such that val(f (v i )) < val(f (v j )) for large i < j < λ. Note that deg h > 1 because (v j ) j<λ has no pseudo limits in K (see the proof of [3,Theorem 3]) and so [K ′ : K(h(x))] = deg h > 1.\\n\\nIf v has no pseudo limits in K(h(x)) then we may take K 1 = K. If v has a pseudo limit in K(h(x)) then we may complete it to a pseudo convergent sequencẽ v =ṽ j<λ overṼ = V ′ ∩ K(h(x)) with x as a pseudo limit, which has no pseudo limit in K(h(x)) using again [3, Theorem 1]. As above there exists a polynomial h ∈Ṽ [Y ] which has minimal degree among all polynomials f ∈Ṽ [Y ] such that val(f (ṽ j )) < val(f (ṽ j+1 )) for large j <λ.\\n\\nFor our proof it is enough to change K by K(h(x)), h byh and v byṽ. If the new v has a pseudo limit in the new K(h(x)) then we proceed as above finding a newṽ and a newh and again we may change K by K(h(x)) and v, h withṽ,h. Proceeding in this way we arrive in some steps (K ′ /K is finite) in the case when v has no pseudo limit in K(h(x)). It is enough to take K 1 to be this new K.\\n\\nProposition 8. Let V ′ be an immediate extension of a valuation ring V , K ⊂ K ′ their fraction field extension and K ′ = K(x) for some x ∈ V ′ algebraic over K. Then V ′ is a filtered union of its complete intersection V -subalgebras.\\n\\nProof. We may assume K = K ′ . By Lemma 7 there exists K 1 ⊂ K ′ , K 1 = K ′ containing K such that x is a pseudo limit of an algebraic pseudo-convergent sequence\\nv = (v j ) j<λ in V 1 = V ′ ∩ K 1 and for a polynomial h ∈ V 1 [Y ] with minimal degree among the polynomials f ∈ V 1 [Y ]\\nwith val(f (v i )) < val(f (v j )) for large i < j < λ there exists no pseudo limit of v in K 1 (h(x)). Set g =Irr(x, K 1 (h(x))). By Lemma\\n4 (1) we have deg h ≤ deg g. But x is a root of g ′ = h(Y ) − h(x) ∈ K 1 (h(x))[Y ] and so g divides g ′ . Thus g is g ′ multiplied with a unit of V ′′ = V ′ ∩ K 1 (h(x)) because deg g ′ = deg h ≤ deg g ≤ deg g ′ .\\nApplying Lemma 4 (2), we see that V ′ is a filtered union of its complete intersection V ′′ -subalgebras. Use induction on [K ′ : K], case K = K ′ being trivial. By induction hypothesis V ′′ is a filtered union of its complete intersection V -subalgebras. Therefore, V ′ is also a filtered union of its complete intersection V -subalgebras using Lemma 6.\\n\\nProof of Theorem 1. Firstly assume K ′ /K is finite, let us say K ′ = K(x 1 , . . . , x n ). Set V i = V ′ ∩ K(x 1 , . . . , x i ), 1 ≤ i < n and V 0 = V , V n = V ′ . Then V i+1 is a filtered union of its complete intersection V i -algebras for all 0 ≤ i < n by Proposition 8 and Lemma 6, which is enough. In general, express K ′ as a filtered union of some subfields (K i ) i of K ′ which are finite extensions of K. Then V ′ is a filtered increasing union of V ′ ∩ K i .\\n\\n\\nRemark 9.\\n\\nIf V is a valuation ring of characteristic = 0 then an algebraic separable valuation ring extension of it may fail to be a filtered direct limit of smooth Valgebras, for instance by [9, Example 3.13, Theorem 6.9, Remark 6.10] (see [6,Sect 9, No 57]); but it is a filtered union of its complete intersection V -subalgebras as in Theorem 1.\\n\\n\\nConflict of Interests/Competing Interests are missing\\n\\nWe have no conflict of interests.\\n\\n\\nwhich is filtered increasing as in the proof of [8, Lemma 3.2], or [10, Lemma 15]. We have\\nThe polynomials D (n) f ∈ R[Y ] for f ∈ R[Y ], the so called Hasse-Schmidt derivatives, make sense for any ring R: indeed, one constructs the Taylor expansion in the universal case R = Z[a 0 , . . . , a deg f ] by using the equality n! · (D (n) f ) = f (n) and verifying over Frac(R).\\n\\nValuation rings are derived splinters. B Antieau, R Datta, arxiv/AG:2002.010627v1Math. Zeitschrift. 299B. Antieau and R. Datta, Valuation rings are derived splinters, Math. Zeitschrift, 299, (2021, 827-851, arxiv/AG:2002.010627v1.\\n\\nSmoothness, semi-stability and alterations. A J De, Jong , Inst. Hautes Études Sci. Publ. Math. 83A. J. de Jong, Smoothness, semi-stability and alterations, Inst. Hautes Études Sci. Publ. Math. (1996), no. 83, 51-93.\\n\\nMaximal fields with valuations. I Kaplansky, Duke Math. J. 9I. Kaplansky, Maximal fields with valuations, Duke Math. J. 9 (1942), 303-321.\\n\\nUpper Ramification Groups for Arbitrary Valuation Rings. K Kato, V Thatte, arXiv/AC:1909.09832v1K. Kato, V. Thatte, Upper Ramification Groups for Arbitrary Valuation Rings, arXiv/AC:1909.09832v1.\\n\\nVlahu The relative approximation degree in valued function fields. F V Kuhlmann, I , Math. Z. 276F. V. Kuhlmann, I. Vlahu The relative approximation degree in valued function fields, Math. Z., 276, (2014), 203-235.\\n\\nUntersuchungen zur arithmetischen Theorie der Körper. A Ostrowski, Math. Z. 391A. Ostrowski, Untersuchungen zur arithmetischen Theorie der Körper, Math. Z. 39 (1935), no. 1, 321-404.\\n\\nGeneral Neron Desingularization and approximation. D Popescu, Nagoya Math. J. 104D. Popescu, General Neron Desingularization and approximation, Nagoya Math. J., 104, (1986), 85-115.\\n\\nOn Zariski's uniformization theorem, in Algebraic geometry. D Popescu, Lecture Notes in Math. 1056SpringerD. Popescu, On Zariski's uniformization theorem, in Algebraic geometry, Bucharest 1982 (Bucharest, 1982), Lecture Notes in Math., vol. 1056, Springer, Berlin, 1984, 264-296.\\n\\nAlgebraic extensions of valued fields. D Popescu, J. Algebra. 1082D. Popescu, Algebraic extensions of valued fields, J. Algebra 108, (1987), no. 2, 513-533.\\n\\nNéron desingularization of extensions of valuation rings with an Appendix by Kęstutis Česnavičius. D Popescu, arxiv/AC:1910.09123v4Transcendence in Algebra, Combinatorics, Geometry and Number Theory. Alin Bostan, Kilian Raschel373Springer Proceedings in Mathematics and StatisticsD. Popescu, Néron desingularization of extensions of valuation rings with an Appendix by Kęstutis Česnavičius, in \\\"Transcendence in Algebra, Com- binatorics, Geometry and Number Theory\\\", Eds. Alin Bostan, Kilian Raschel, Springer Proceedings in Mathematics and Statistics 373, 275-307, arxiv/AC:1910.09123v4.\\n\\nThe theory of valuations, Mathematical Surveys, Number IV. O F G Schilling, American Math. SocO. F. G. Schilling, The theory of valuations, Mathematical Surveys, Number IV, American Math. Soc., (1950).\\n\\nNeron-Popescu desingularization, in \\\"Algebra and Geometry. R Swan, M. Kang, International PressCambridgeR. Swan, Neron-Popescu desingularization, in \\\"Algebra and Geometry\\\", Ed. M. Kang, International Press, Cambridge, (1998), 135-192.\\n\\nThe Stacks Project. A J De, Jong , A. J. de Jong et al., The Stacks Project. Available at http://stacks.math.columbia.edu.\\n\\nTame distillation and desingularization by p-alterations. M Temkin, Ann. of Math. 2M. Temkin, Tame distillation and desingularization by p-alterations, Ann. of Math. (2) 186 (2017), no. 1, 97-126.\\n\\nRamification theory for Artin-Schreier extensions of valuation rings. V Thatte, J. Algebra. 456V. Thatte, Ramification theory for Artin-Schreier extensions of valuation rings, J. Algebra, 456, (2016), 355-389.\\n\\nRamification theory for degree p extensions of arbitrary valuation rings in mixed characteristic (0, p). V Thatte, J. Algebra. 507V. Thatte, Ramification theory for degree p extensions of arbitrary valuation rings in mixed characteristic (0, p), J. Algebra, 507, (2018), 225-248.\\n\\nLocal uniformization on algebraic varieties. O Zariski, Ann. of Math. 41O. Zariski, Local uniformization on algebraic varieties, Ann. of Math. 41 (1940), 852-896,\\n\\n. Faculty of Mathematics and Computer Science Str. Academiei. 14Simion Stoilow Institute of Mathematics of the Romanian AcademyResearch unit 5, P.O. Box 1-764Simion Stoilow Institute of Mathematics of the Romanian Academy, Research unit 5, P.O. Box 1-764, Bucharest 014700, Romania, University of Bucharest, Faculty of Mathematics and Computer Science Str. Academiei 14, Bucharest 1, RO-010014, Romania, Email: dorin.popescu@imar.ro\\n\",\"annotations\":{\"abstract\":\"[{\\\"end\\\":541,\\\"start\\\":387}]\",\"author\":\"[{\\\"end\\\":108,\\\"start\\\":94}]\",\"authoraffiliation\":null,\"authorfirstname\":\"[{\\\"end\\\":99,\\\"start\\\":94}]\",\"authorlastname\":\"[{\\\"end\\\":107,\\\"start\\\":100}]\",\"bibauthor\":\"[{\\\"end\\\":13526,\\\"start\\\":13515},{\\\"end\\\":13535,\\\"start\\\":13526},{\\\"end\\\":13760,\\\"start\\\":13752},{\\\"end\\\":13767,\\\"start\\\":13760},{\\\"end\\\":13971,\\\"start\\\":13958},{\\\"end\\\":14131,\\\"start\\\":14123},{\\\"end\\\":14141,\\\"start\\\":14131},{\\\"end\\\":14344,\\\"start\\\":14330},{\\\"end\\\":14348,\\\"start\\\":14344},{\\\"end\\\":14546,\\\"start\\\":14533},{\\\"end\\\":14725,\\\"start\\\":14714},{\\\"end\\\":14917,\\\"start\\\":14906},{\\\"end\\\":15177,\\\"start\\\":15166},{\\\"end\\\":15395,\\\"start\\\":15384},{\\\"end\\\":15951,\\\"start\\\":15934},{\\\"end\\\":16145,\\\"start\\\":16137},{\\\"end\\\":16342,\\\"start\\\":16334},{\\\"end\\\":16349,\\\"start\\\":16342},{\\\"end\\\":16506,\\\"start\\\":16496},{\\\"end\\\":16716,\\\"start\\\":16706},{\\\"end\\\":16962,\\\"start\\\":16952},{\\\"end\\\":17184,\\\"start\\\":17173}]\",\"bibauthorfirstname\":\"[{\\\"end\\\":13516,\\\"start\\\":13515},{\\\"end\\\":13527,\\\"start\\\":13526},{\\\"end\\\":13753,\\\"start\\\":13752},{\\\"end\\\":13755,\\\"start\\\":13754},{\\\"end\\\":13764,\\\"start\\\":13760},{\\\"end\\\":13959,\\\"start\\\":13958},{\\\"end\\\":14124,\\\"start\\\":14123},{\\\"end\\\":14132,\\\"start\\\":14131},{\\\"end\\\":14331,\\\"start\\\":14330},{\\\"end\\\":14333,\\\"start\\\":14332},{\\\"end\\\":14345,\\\"start\\\":14344},{\\\"end\\\":14534,\\\"start\\\":14533},{\\\"end\\\":14715,\\\"start\\\":14714},{\\\"end\\\":14907,\\\"start\\\":14906},{\\\"end\\\":15167,\\\"start\\\":15166},{\\\"end\\\":15385,\\\"start\\\":15384},{\\\"end\\\":15935,\\\"start\\\":15934},{\\\"end\\\":15939,\\\"start\\\":15936},{\\\"end\\\":16138,\\\"start\\\":16137},{\\\"end\\\":16335,\\\"start\\\":16334},{\\\"end\\\":16337,\\\"start\\\":16336},{\\\"end\\\":16346,\\\"start\\\":16342},{\\\"end\\\":16497,\\\"start\\\":16496},{\\\"end\\\":16707,\\\"start\\\":16706},{\\\"end\\\":16953,\\\"start\\\":16952},{\\\"end\\\":17174,\\\"start\\\":17173}]\",\"bibauthorlastname\":\"[{\\\"end\\\":13524,\\\"start\\\":13517},{\\\"end\\\":13533,\\\"start\\\":13528},{\\\"end\\\":13758,\\\"start\\\":13756},{\\\"end\\\":13969,\\\"start\\\":13960},{\\\"end\\\":14129,\\\"start\\\":14125},{\\\"end\\\":14139,\\\"start\\\":14133},{\\\"end\\\":14342,\\\"start\\\":14334},{\\\"end\\\":14544,\\\"start\\\":14535},{\\\"end\\\":14723,\\\"start\\\":14716},{\\\"end\\\":14915,\\\"start\\\":14908},{\\\"end\\\":15175,\\\"start\\\":15168},{\\\"end\\\":15393,\\\"start\\\":15386},{\\\"end\\\":15949,\\\"start\\\":15940},{\\\"end\\\":16143,\\\"start\\\":16139},{\\\"end\\\":16340,\\\"start\\\":16338},{\\\"end\\\":16504,\\\"start\\\":16498},{\\\"end\\\":16714,\\\"start\\\":16708},{\\\"end\\\":16960,\\\"start\\\":16954},{\\\"end\\\":17182,\\\"start\\\":17175}]\",\"bibentry\":\"[{\\\"attributes\\\":{\\\"doi\\\":\\\"arxiv/AG:2002.010627v1\\\",\\\"id\\\":\\\"b0\\\",\\\"matched_paper_id\\\":211020921},\\\"end\\\":13706,\\\"start\\\":13476},{\\\"attributes\\\":{\\\"id\\\":\\\"b1\\\",\\\"matched_paper_id\\\":9727824},\\\"end\\\":13924,\\\"start\\\":13708},{\\\"attributes\\\":{\\\"id\\\":\\\"b2\\\"},\\\"end\\\":14064,\\\"start\\\":13926},{\\\"attributes\\\":{\\\"doi\\\":\\\"arXiv/AC:1909.09832v1\\\",\\\"id\\\":\\\"b3\\\"},\\\"end\\\":14261,\\\"start\\\":14066},{\\\"attributes\\\":{\\\"id\\\":\\\"b4\\\",\\\"matched_paper_id\\\":17292389},\\\"end\\\":14477,\\\"start\\\":14263},{\\\"attributes\\\":{\\\"id\\\":\\\"b5\\\",\\\"matched_paper_id\\\":118173600},\\\"end\\\":14661,\\\"start\\\":14479},{\\\"attributes\\\":{\\\"id\\\":\\\"b6\\\",\\\"matched_paper_id\\\":121972960},\\\"end\\\":14844,\\\"start\\\":14663},{\\\"attributes\\\":{\\\"id\\\":\\\"b7\\\"},\\\"end\\\":15125,\\\"start\\\":14846},{\\\"attributes\\\":{\\\"id\\\":\\\"b8\\\",\\\"matched_paper_id\\\":119626614},\\\"end\\\":15283,\\\"start\\\":15127},{\\\"attributes\\\":{\\\"doi\\\":\\\"arxiv/AC:1910.09123v4\\\",\\\"id\\\":\\\"b9\\\",\\\"matched_paper_id\\\":219249566},\\\"end\\\":15873,\\\"start\\\":15285},{\\\"attributes\\\":{\\\"id\\\":\\\"b10\\\"},\\\"end\\\":16076,\\\"start\\\":15875},{\\\"attributes\\\":{\\\"id\\\":\\\"b11\\\"},\\\"end\\\":16312,\\\"start\\\":16078},{\\\"attributes\\\":{\\\"id\\\":\\\"b12\\\"},\\\"end\\\":16436,\\\"start\\\":16314},{\\\"attributes\\\":{\\\"id\\\":\\\"b13\\\",\\\"matched_paper_id\\\":119149302},\\\"end\\\":16634,\\\"start\\\":16438},{\\\"attributes\\\":{\\\"id\\\":\\\"b14\\\",\\\"matched_paper_id\\\":119648767},\\\"end\\\":16845,\\\"start\\\":16636},{\\\"attributes\\\":{\\\"id\\\":\\\"b15\\\",\\\"matched_paper_id\\\":119281280},\\\"end\\\":17126,\\\"start\\\":16847},{\\\"attributes\\\":{\\\"id\\\":\\\"b16\\\",\\\"matched_paper_id\\\":124033355},\\\"end\\\":17290,\\\"start\\\":17128},{\\\"attributes\\\":{\\\"id\\\":\\\"b17\\\"},\\\"end\\\":17724,\\\"start\\\":17292}]\",\"bibref\":\"[{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b16\\\"},\\\"end\\\":681,\\\"start\\\":677},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b1\\\"},\\\"end\\\":891,\\\"start\\\":888},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b0\\\"},\\\"end\\\":1097,\\\"start\\\":1094},{\\\"end\\\":1113,\\\"start\\\":1097},{\\\"end\\\":1262,\\\"start\\\":1252},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b12\\\"},\\\"end\\\":1270,\\\"start\\\":1266},{\\\"end\\\":1275,\\\"start\\\":1270},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b5\\\"},\\\"end\\\":1670,\\\"start\\\":1667},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b8\\\"},\\\"end\\\":1684,\\\"start\\\":1681},{\\\"end\\\":1696,\\\"start\\\":1684},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b14\\\"},\\\"end\\\":1936,\\\"start\\\":1932},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":1942,\\\"start\\\":1938},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b6\\\"},\\\"end\\\":2191,\\\"start\\\":2188},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b11\\\"},\\\"end\\\":2197,\\\"start\\\":2193},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b11\\\"},\\\"end\\\":3046,\\\"start\\\":3042},{\\\"end\\\":3058,\\\"start\\\":3046},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b10\\\"},\\\"end\\\":4444,\\\"start\\\":4440},{\\\"end\\\":4448,\\\"start\\\":4444},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b3\\\"},\\\"end\\\":4450,\\\"start\\\":4448},{\\\"end\\\":4460,\\\"start\\\":4452},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b1\\\"},\\\"end\\\":7131,\\\"start\\\":7128},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b2\\\"},\\\"end\\\":8217,\\\"start\\\":8214},{\\\"end\\\":8226,\\\"start\\\":8217},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b2\\\"},\\\"end\\\":10074,\\\"start\\\":10071},{\\\"end\\\":10084,\\\"start\\\":10074},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b5\\\"},\\\"end\\\":12901,\\\"start\\\":12898},{\\\"end\\\":12907,\\\"start\\\":12901}]\",\"bibtitle\":\"[{\\\"end\\\":13513,\\\"start\\\":13476},{\\\"end\\\":13750,\\\"start\\\":13708},{\\\"end\\\":13956,\\\"start\\\":13926},{\\\"end\\\":14328,\\\"start\\\":14263},{\\\"end\\\":14531,\\\"start\\\":14479},{\\\"end\\\":14712,\\\"start\\\":14663},{\\\"end\\\":14904,\\\"start\\\":14846},{\\\"end\\\":15164,\\\"start\\\":15127},{\\\"end\\\":15382,\\\"start\\\":15285},{\\\"end\\\":16494,\\\"start\\\":16438},{\\\"end\\\":16704,\\\"start\\\":16636},{\\\"end\\\":16950,\\\"start\\\":16847},{\\\"end\\\":17171,\\\"start\\\":17128}]\",\"bibvenue\":\"[{\\\"end\\\":13574,\\\"start\\\":13557},{\\\"end\\\":13802,\\\"start\\\":13767},{\\\"end\\\":13983,\\\"start\\\":13971},{\\\"end\\\":14121,\\\"start\\\":14066},{\\\"end\\\":14355,\\\"start\\\":14348},{\\\"end\\\":14553,\\\"start\\\":14546},{\\\"end\\\":14739,\\\"start\\\":14725},{\\\"end\\\":14938,\\\"start\\\":14917},{\\\"end\\\":15187,\\\"start\\\":15177},{\\\"end\\\":15483,\\\"start\\\":15416},{\\\"end\\\":15932,\\\"start\\\":15875},{\\\"end\\\":16135,\\\"start\\\":16078},{\\\"end\\\":16332,\\\"start\\\":16314},{\\\"end\\\":16518,\\\"start\\\":16506},{\\\"end\\\":16726,\\\"start\\\":16716},{\\\"end\\\":16972,\\\"start\\\":16962},{\\\"end\\\":17196,\\\"start\\\":17184},{\\\"end\\\":17352,\\\"start\\\":17294}]\",\"figure\":\"[{\\\"attributes\\\":{\\\"id\\\":\\\"tab_0\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":13189,\\\"start\\\":13097}]\",\"figurecaption\":\"[{\\\"end\\\":13189,\\\"start\\\":13099}]\",\"figureref\":null,\"formula\":\"[{\\\"attributes\\\":{\\\"id\\\":\\\"formula_0\\\"},\\\"end\\\":4356,\\\"start\\\":3873},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_1\\\"},\\\"end\\\":4922,\\\"start\\\":4868},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_2\\\"},\\\"end\\\":5642,\\\"start\\\":5352},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_3\\\"},\\\"end\\\":5956,\\\"start\\\":5676},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_4\\\"},\\\"end\\\":6305,\\\"start\\\":6179},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_5\\\"},\\\"end\\\":6434,\\\"start\\\":6339},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_6\\\"},\\\"end\\\":6799,\\\"start\\\":6699},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_7\\\"},\\\"end\\\":7597,\\\"start\\\":7366},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_8\\\"},\\\"end\\\":7937,\\\"start\\\":7597},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_9\\\"},\\\"end\\\":8895,\\\"start\\\":8436},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_10\\\"},\\\"end\\\":9145,\\\"start\\\":9028},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_11\\\"},\\\"end\\\":11468,\\\"start\\\":11346},{\\\"attributes\\\":{\\\"id\\\":\\\"formula_12\\\"},\\\"end\\\":11823,\\\"start\\\":11609}]\",\"paragraph\":\"[{\\\"end\\\":1446,\\\"start\\\":557},{\\\"end\\\":2199,\\\"start\\\":1448},{\\\"end\\\":3224,\\\"start\\\":2201},{\\\"end\\\":3287,\\\"start\\\":3226},{\\\"end\\\":3509,\\\"start\\\":3289},{\\\"end\\\":3872,\\\"start\\\":3563},{\\\"end\\\":4867,\\\"start\\\":4357},{\\\"end\\\":5118,\\\"start\\\":4923},{\\\"end\\\":5351,\\\"start\\\":5120},{\\\"end\\\":5675,\\\"start\\\":5643},{\\\"end\\\":6178,\\\"start\\\":5957},{\\\"end\\\":6338,\\\"start\\\":6306},{\\\"end\\\":6451,\\\"start\\\":6435},{\\\"end\\\":6698,\\\"start\\\":6453},{\\\"end\\\":7004,\\\"start\\\":6800},{\\\"end\\\":7365,\\\"start\\\":7006},{\\\"end\\\":8109,\\\"start\\\":7938},{\\\"end\\\":8228,\\\"start\\\":8111},{\\\"end\\\":8435,\\\"start\\\":8230},{\\\"end\\\":9027,\\\"start\\\":8896},{\\\"end\\\":9689,\\\"start\\\":9146},{\\\"end\\\":10121,\\\"start\\\":9691},{\\\"end\\\":10558,\\\"start\\\":10123},{\\\"end\\\":10944,\\\"start\\\":10560},{\\\"end\\\":11181,\\\"start\\\":10946},{\\\"end\\\":11345,\\\"start\\\":11183},{\\\"end\\\":11608,\\\"start\\\":11469},{\\\"end\\\":12178,\\\"start\\\":11824},{\\\"end\\\":12653,\\\"start\\\":12180},{\\\"end\\\":13005,\\\"start\\\":12667},{\\\"end\\\":13096,\\\"start\\\":13063}]\",\"publisher\":null,\"sectionheader\":\"[{\\\"end\\\":555,\\\"start\\\":543},{\\\"attributes\\\":{\\\"n\\\":\\\"1.\\\"},\\\"end\\\":3561,\\\"start\\\":3512},{\\\"end\\\":12665,\\\"start\\\":12656},{\\\"attributes\\\":{\\\"n\\\":\\\"2.\\\"},\\\"end\\\":13061,\\\"start\\\":13008}]\",\"table\":null,\"tableref\":null,\"title\":\"[{\\\"end\\\":80,\\\"start\\\":1},{\\\"end\\\":188,\\\"start\\\":109}]\",\"venue\":null}},\"updated\":\"2023-06-02T15:33:02Z\"}\n",
      "\n",
      "{\"corpusid\":258428602,\"externalids\":{\"arxiv\":null,\"mag\":null,\"acl\":null,\"pubmed\":\"37223628\",\"pubmedcentral\":\"10202571\",\"dblp\":null,\"doi\":\"10.1055/s-0043-1764306\"},\"content\":{\"source\":{\"pdfurls\":null,\"pdfsha\":\"d6ebebca1b30609ac9bc1fc522983edd41a9e350\",\"oainfo\":{\"license\":\"CCBY\",\"openaccessurl\":\"https://doi.org/10.1055/s-0043-1764306\",\"status\":\"GOLD\"}},\"text\":\"\\n88 Re-N-DEDC Lipiodol for Treatment of Hepatocellular Carcinoma (HCC)-A Clinical and Prospective Study to Assess In-Vivo Distribution in Patients and Clinical Feasibility of Therapy\\n2023\\n\\nNaresh Kumar \\nDepartment of Nuclear Medicine\\nAll India Institute of Medical Sciences (AIIMS)\\nNew DelhiIndia\\n\\nPriyanka Gupta \\nDepartment of Nuclear Medicine\\nAll India Institute of Medical Sciences (AIIMS)\\nNew DelhiIndia\\n\\nShamim Ahmed Shamim sashamim2002@gmail.com. \\nDepartment of Nuclear Medicine\\nAll India Institute of Medical Sciences (AIIMS)\\nNew DelhiIndia\\n\\nViju Chirayil \\nThieme Medical and Scientific Publishers Pvt. Ltd., A-12, 2nd Floor\\nBhabha Atomic Research Centre\\nSector 2, Noida-201301 UPMumbaiMaharashtraIndia World, India Original Article\\n\\nSuresh Subramanian \\nThieme Medical and Scientific Publishers Pvt. Ltd., A-12, 2nd Floor\\nBhabha Atomic Research Centre\\nSector 2, Noida-201301 UPMumbaiMaharashtraIndia World, India Original Article\\n\\nMadhava B Mallia \\nThieme Medical and Scientific Publishers Pvt. Ltd., A-12, 2nd Floor\\nBhabha Atomic Research Centre\\nSector 2, Noida-201301 UPMumbaiMaharashtraIndia World, India Original Article\\n\\nChandrasekhar Bal \\nDepartment of Nuclear Medicine\\nAll India Institute of Medical Sciences (AIIMS)\\nNew DelhiIndia\\n\\n88 Re-N-DEDC Lipiodol for Treatment of Hepatocellular Carcinoma (HCC)-A Clinical and Prospective Study to Assess In-Vivo Distribution in Patients and Clinical Feasibility of Therapy\\n\\nJ Nuclear Med\\n22202310.1055/s-0043-1764306Address for correspondence Shamim Ahmed Shamim, MD, Department of Nuclear Medicine, AIIMS, New Delhi, 110029, India article published online This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. THIEME 114► hepatocellular carcinoma (HCC) ► trans-arterial radionuclide therapy (TART) ► DEDC (diethydithio- carbamate) ► radiochemical purity (RCP) ► radiochemical yield (RCY)\\nObjective The incidence of inoperable hepatocellular carcinoma (HCC) with/without malignant portal vein thrombosis (PVT) is increasing in India for the last decade; thus, Bhabha Atomic Research Centre (BARC), Mumbai, India, developed diethydithiocarbamate (DEDC), a new transarterial radionuclide therapy (TART) agent. 188 Re-N-DEDC lipiodol is an emerging radiotherapeutic agent for inoperable HCC treatment due to its simple and onsite labeling procedure, cost-effectiveness, and least radiation-induced side effects. This study aimed to evaluate in-vivo biodistribution and clinical feasibility of 188 Re-N-DEDC lipiodol TART in HCC and optimization of labeling procedure to assess post-labeling stability and radiochemical yield of labeled lipiodol with 188 Re-N-DEDC complex. Materials and Methods DEDC kits were obtained as gift from BARC, Mumbai. Therapy was given to 31 HCC patients. Post-therapy planar and single-photon emission computed tomography/computed tomography (SPECT/CT) imaging were performed to see tumor uptake and biodistribution. Clinical feasibility and toxicity were decided by Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v 5.0). Statistical Analysis Descriptive statistics was done for data using SPSS v22. Values was expressed as mean AE standard deviation or median with range. Results Post-therapy planar and SPECT/CT imaging showed radiotracer localization in hepatic lesions. Few patients showed lungs uptake due to hepato-pulmonary shunt (lung shunt < 10%). Maximum clearance was observed through urinary tract with very less elimination through hepatobiliary route due to slow rate of leaching of tracer. No patient showed myelosuppression or any other long-term toxicity over median followup of 6 months. Mean overall % radiochemical yield of 188 Re-N-DEDC lipiodol was 86.04 AE 2.35%. The complex 188 Re-N-DEDC was found to be stable at 37°C under sterile condition over a period of 1 hour without any significant change on the % radiochemical purity (90.83 AE 3.24%, 89.78 AE 3.67%, 89.22 AE 3.77% at 0, 0.5, 1 hours, respectively).Conclusion Human biodistribution showed very high retention of radiotracer in hepatic lesions with no long-term toxicity with this therapy. The kit preparation procedure is ideally suited for a busy hospital radio-pharmacy. By this procedure, 188 Re-N-DEDC lipiodol can be prepared in high radiochemical yield within a short time ($45 minutes). Thus, 188 Re-N-DEDC lipiodol can be considered for TART in advanced and/or intermediate HCC.\\n\\nIntroduction\\n\\nHepatocellular carcinoma (HCC) is one of the most common cancers, being fifth most frequent malignancy and the third leading cause of cancer death worldwide. 1 A range of 70 to 95% of HCC occurs in cirrhotic patients in Asian population. 2,3 Hepatitis B or C viruses, direct chronic exposure to aflatoxins, chronic alcohol consumption (> 50-70 g/day for prolonged time), and use of estrogen-containing oral contraceptives (> 5 years) are the well-established risk factors for HCC. 4 The highest age standardized incidence as well as mortality rate per 100,000 population is notable in Mongolia in East Asia. Globally, the diverse HCC incidence is due to the variable prevalence of associated etiologies. 5 A recent publication projecting HCC incidences in 30 countries worldwide that predicts the percentage change in age standardized incidence rate over a period of 25 years, from 2005 to 2030. There is a drop in chronic viral hepatitis-related HCC incidences, with an increased nonalcoholic steatohepatitis (NASH)-related HCC incidences by 122% between 2016 and 2030 in United States. 6,7 The prognosis for HCC is extremely poor, and the treatment depends on the disease extent and staging. The Barcelona Clinic Liver Cancer (BCLC) staging system is the most common and frequently used staging in HCC. This includes four components, that is, tumor extension, liver functional reserve (Child-Pugh stage), physical status (Eastern Cooperative Oncology Group [ECOG] performance status), and cancer-related symptoms. In addition to prognostication, the BCLC staging system also recommends appropriate management options as per each stage. The curative treatment (surgery or local ablative procedures) can only be carried out in only 20 to 30% of cases in very early stage (stage 0) and early stage (stage A). 8 Intermediate stage (stage B) and advanced stage (stage C) patients may receive palliative treatments such as radio frequency ablation, transarterial chemoembolization, selective internal radiation therapy (SIRT)/transarterial radioembolization (TARE), or systemic therapy. 9,10 Currently, sorafenib or lenvatinib is the standard first-line systemic therapy for advanced stage HCC patients. 11,12 End-stage patients (stage D) often receive symptomatic treatment or best supportive care. 8 SIRT/TARE is an internal targeted radiation therapeutic technique with the use of various β-emitting radionuclides (such as yttrium-90, holmium-166, iodine-131, and rhenium-188) for the locoregional treatment for intermediate or advanced HCC. 13 90 Y-microsphere is contraindicated in patients with severe abnormal liver function because of its embolic nature, the cost per therapy up to 10 times higher than 131 I-lipiodol and Rhenium-188 nitrido-diethyldithiocarbamate ( 188 Re-N-DEDC) lipiodol therapy, and significant bone marrow toxicity with 90 Y-labeled compounds because of high rates of leaching over time. 14 188 Re-N-DEDC lipiodol is an emerging agent for transarterial radionuclide therapy (TART) in HCC patients. Rhenium-188 has a half-life of 16.9 hours, high beta energy (E βmax ¼ 2.1 MeV) close to 90 Y (E βmax ¼ 2.28 MeV) with t 1/2 ¼ 64.1 hours, and comparable maximum range of 11 mm in tissue. Low gamma energy 155 keV (15% abundance) emission is appropriate for monitoring of the localization of radiopharmaceutical in the target tissue, imaging, and patient-specific dosimetry. 15 The improved 4-hexadecyl-4, 7-diaza 1, 10-decanedithioacetate (AHDD) kits conjugated with 188 Re-lipiodol were safely used in HCC patients (BCLC-B and C). 16 Unfortunately, the radiochemical yield (RCY) is limited to under 70 to 80%; therefore, higher activity needs to be added to synthesize desired activity that may lead to high exposure to researcher. 16,17 Due to unpredictable and low RCY, researchers are looking for an alternative to AHDD having similar biodistribution and clinical feasibility but higher RCY with 188 Re. DEDC labeled with 188 Re is another TART agent that had proven its efficacy for the therapy of unresectable liver cancer. The preclinical trials with 188 Re-N-DEDC lipiodol showed retention of activity in liver with no detectable levels of activity in lungs, kidneys, or any other vital organs. 18 The preparation of DEDC kits require addition of stipulated quantity of glacial acetic acid that might lead to low radiochemical purity (RCP) of 188 Re-N-DEDC complex and less RCY than expected if any error in quantity of acetic acid. Most of radiopharmacy operations prefer acetic acid free preparation; therefore, recently an improved freezedried kit developed by Bhabha Atomic Research Centre (BARC), Mumbai, that uses sodium oxalate buffer which can significantly improve the %RCP of the complex. Thus, the recently developed improved DEDC kit can be used for 188 Re-N-DEDC lipiodol labeling to overcome the drawbacks with AHDD kits. 19 This study aimed for the optimization of improved labeling procedure to get maximum RCY, assessment of stability of 188 Re-N-DEDC complex at optimal temperature, and final % RCY in lipiodol phase. Also, the study prospectively assessed the human in-vivo biodistribution and feasibility of TART with 188 Re-N-DEDC lipiodol from clinical as well as radiation protection point of view.\\n\\n\\nMaterials and Methods\\n\\n\\nRadiochemistry and Standardized Labeling Procedure\\n\\nLyophilized freeze-dried kits (containing 2 vials [vial-1 and vial-2]) of DEDC were obtained as gift from BARC, Mumbai, India. The kits were prepared under sterile condition and sterility was checked prior to supply by BARC. The labeling was performed by using freshly eluted 188 Re-sodium-perrhenate obtained from commercial 188 W/ 188 Re-generator (PARS Rhen 188 W/ 188 Re generator).\\n\\nVial 1 contains 2 mg N-methyl-S-methyl dithiocarbazate (DTCz), 10 mg sodium ascorbate, 28 mg oxalic acid, 0.8 mg SnCl 2 .2H 2 O, while vial 2 contains 100 mg DEDC in freeze dried form. The species DTCz was an efficient nitrido donor (N 3À ), SnCl 2 as reducing agent and oxalic acid played important role in expanding the coordination sphere of the 188 Re-(VII) ion required for improved radiopharmaceutical yield. 188 Re-labeled-lipiodol was obtained by dissolving 188 Re-N-DEDC complex in lipiodol (lipiodol ultra-fluid, Guerbet, France).\\n\\nThe standard labeling procedure involved the addition of required sodium perrhenate activity (independent of volume) to vial-1 that form intermediate 188 Re-nitrido complex ( 188 Re N 2þ ). After 5 minutes of incubation, 1 mL reconstituted solvent of vial 2 was added to the vial 1 that led to formation of yellow color precipitate confirming the correct labeling procedure. Further, the intermediate mixture was made to stand for 15 minutes at room temperature and required more incubation at 65°C for 5 minutes in a water bath, thus enabling the formation of 188 Re-N-DEDC complex. Lipiodol (up to 4 mL) was added in labeled 188 Re-N-DEDC complex. The solution was thoroughly homogenized for approximately 10 minutes with a rotary vortex mixer and then centrifuged at 3,500 rpm for 15 minutes at 4°C. Thus, radiolabeled lipiodol was extracted from bottom of mixture vial using a spinal needle under controlled air conditions by putting an air vent in vial for easier separation of both layers. The reactions involving the formation of 188 Re-N-DEDC lipiodol given in ►Fig. 1.\\n\\nAfter 188 Re-N-DEDC complex formation, %RCP of complex was assessed as the percentage ratio of the radioactivity of labeled 188 Re-N-DEDC complex over the total activity of free 188 Re-sodium perrhenate. %RCP was carried out with thinlayer chromatography (TLC) silica gel (SG) 60 F 254 aluminumbacked strips obtained from Merck (Darmstadt, Germany) or Whatman paper no. 1 as stationary phase; dichloromethane (Fisher scientific, New Hampshire, United states) as mobile phase and counting was performed by well counter (Biodex Atomlab 950 thyroid uptake system with optional well counter).\\n\\nAbout 0.5 µL (upto 3 µCi) of 188 Re-N-DEDC complex was applied on two different TLC strips and developed into dichloromethane. After drying with air drier, one strip was cut into two equal halves and other was cut into ten equal halves; the radioactivity of each part was counted using well counter to assess %RCP and retention factor (R f ) of the complex, respectively. The piece with maximum count indicated the retention factor of the complex.\\n\\nThe %RCY was calculated as the percentage ratio of final radioactivity of 188 Re-N-DEDC lipiodol obtained after its radiochemical separation from aqueous free perrhenate and total activity added in reaction vial-1 during preparation. The post-labeling stability of 188 Re-N-DEDC complex was checked to assess %RCP at various time points 0, 0.5, 1, 2, 3, 6, 12, and 24 hours at 37°C under sterile condition. Also, the %RCY of 188 Re-N-DEDC-lipiodol after 24 hours was also performed. The reproducibility of radiolabeling was assessed in 18 tests with DEDC kits.\\n\\n\\nHuman Biodistribution and Clinical Feasibility\\n\\nRadiologically and/or histopathologically confirmed intermediate/advanced HCC patients having ECOG performance status of 2 or less and Child-Pugh score A/B were prospectively included in this study. Written informed consent was taken from all the patients. Ethical clearance for the study was obtained from institute ethical clearance committee (IECPG-755/23.12.2021, RT-03/27.01.2022) for 188 Re-N-DEDC lipiodol TART. Following the labeling procedure, the therapeutic activity (1.5-5 GBq) was injected through tumor feeding artery depending upon tumor size under fluoroscopic guidance through femoral branch in super-selective manner. 18 Planar and single-photon emission computed tomography (SPECT) imaging was performed on Mediso Any Scan SPECT/CT system (Budapest, Hungary) at 2, 6, 12, 24, 48, and 72 hours in nuclear medicine department to see tumor uptake and biodistribution of 188 Re-N-DEDC lipiodol. Planar images were acquired at a scan speed of 150 mm per minute for anterior and posterior whole-body image with matrix size is 256 Â 1,024 and zoom factor is 0.88 (2.73 mm/pixel), SPECT was acquired in continuous mode at projection arc of 2.77 degree with time per projection of 17 seconds, matrix size is 128 Â 128 and zoom factor is 1.14 (4.25 mm/pixel), and CT was acquired at 2 hours imaging time along with SPECT at exposure is 260, tube current (mA) is 390 and tube voltage (kV) is 120.\\n\\nClinical feasibility of therapy was decided on the basis of early or late toxicity evaluations. Clinical and laboratory (investigational) toxicities were graded in accordance with Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v5.0) developed by the National Cancer Institute of the USA.\\n\\n\\nRadiation Exposure\\n\\nThe whole-body radiation dose was measured using electronic pocket dosimeter (ALOKA MYDOSE mini, PDM-222-SH, Southern Scientific Ltd., UK).\\n\\n\\nStatistical Analysis\\n\\nDescriptive statistics has been done for data using SPSS v22. Values have been expressed as mean AE standard deviation or median with range. Data is expressed as mean and number and percentage for qualitative and quantitative variables.\\n\\n\\nResults\\n\\n\\nRadiochemistry and Standard Labeling Procedure\\n\\nStandard labeling procedure using improved DEDC kits containing sodium oxalate buffer took only 45 minutes for synthesis of 188 Re-N-DEDC lipiodol that is less than previously described procedure as well as other commercially available kits. 16,19 The radiolabeling parameters such as %RCP, retention factor of complex, and %RCY in lipiodol phase were assessed in 18 tests with DEDC kits. The data showing number of labeling procedures, activity added, %RCP, and %RCY are given in ►Table 1. ►Fig. 2 shows the trend of %RCP and %RCY with the number of labeling procedures.\\n\\nOn observation, it was noticed that the free sodium perrhenate was spotted at origin, while the labeled complex was present at 0.6 to 0.7 on silica gel or Whatman strip. The radiochromatograph plot to assess %RCP at 0 and 24 hr is indicated in ►Fig. 3. The mean %RCP immediately after labeling of complex was 90.83 AE 3.24. The resulted R f was obtained as 0.6 on TLC radiochromatograph (►Fig. 3A).\\n\\nThe showing mild lung uptake due to hepatopulmonary shunt. All six patients had hepatopulmonary shunt less than 10%; thus, dose reduction was not required in any patient. Faint visualization of kidneys was observed at 2 to 6 hours wholebody imaging with maximum uptake in 24 to 48 hours due to urinary route of elimination. Digestive tract such as small intestine showed increased 188 Re-N-DEDC lipiodol uptake over time (12-24 hrs) due to their lipophilic characteristic and slow elimination through hepatobiliary tract. High bladder uptake was due to urinary excretion as the main route.   Mild uptake of free perrhenate was seen in thyroid and salivary glands of only five patients (~16%). All 31 patients were available for toxicity evaluation, and the median follow-up time was of 6 months (range: 3-12 months). None of the patient had myelosuppression or any other longterm toxicity. Post-therapy clinical toxicities (nausea, vomiting, fever, and abdominal pain) were observed in most of the patients for 2 to 3 days and were treated symptomatically.\\n\\nOne patient showed grade 3 liver toxicity and progressive worsening of liver function test, 20 patients showed grade 1 derangements in liver enzymes, and six patients showed grade 2 derangements in liver enzymes and later on toxicity was managed conservatively in hospital lasting for 3 days. Hematological toxicities were seen in four patients ( grade 2) in 2 patients and grade 3 in two patients). The patient with grade 3 hematological toxicity had either low hemoglobin or low  platelet counts at baseline as well as follow-up and required red blood cell (RBC) transfusion or fresh frozen plasma infusion post-therapy, respectively. None of the patient had any pulmonary toxicity that were quantitatively seen by comparing baseline and follow-up pulmonary function test. Patient characteristics, biodistribution, and toxicity evaluation data are given in ►Table 3.\\n\\nThe post-therapy dosimetry was performed in all patients using Monte Carlo methods to estimate radiation absorbed dose to tumor, normal non-neoplastic liver and lungs, and subsequently the radiological, biochemical, and clinical response were assessed at least up to 6 months but are outside the scope of this article. Interestingly, the absorbed dose to normal liver parenchyma and lungs did not exceed 20 and Fig. 6 A 52-year-old male with a known case of hepatitis-C virus and non-alcoholic steatohepatitis -related hepatocellular carcinoma with portal vein thrombosis underwent Rhenium-188-N diethyldithiocarbamate lipiodol transarterial radionuclide therapy; the post-therapy whole-body imaging showing localized tracer uptake up to 72 hours in seg. VI lesion, minimal uptake in salivary gland due to free perrhenate, faint visualization of kidneys in 2 to 6 hours with maximum visualization in 24 to 48 hours, minimal gut uptake over time (12-24 hours), and high bladder uptake due to urinary excretion. 4 Gy, respectively, in any patient, which is well below the maximum tolerated liver dose of 30 and 12 Gy for lungs.\\n\\nDuring the entire synthesis procedure, that is, from elution to post-injection imaging, mean whole-body radiation, dose received by radiation personnel measured by using the pocket dosimeter, was 18 AE 4.73 µSv. The mean wholebody radiation dose during synthesis, quality control (QC), interventional procedure, and imaging was 9.8 AE 2.06, 1.44 AE 0.51, 3.44 AE 0.98, and 3.27 AE 1.18 µSv, respectively.\\n\\n\\nDiscussion\\n\\nLow standard reduction potential (E 0 ) of 188 Re is the major problem in reducing the metal center and also strongly limits the possibility to obtain high yield of 188 Re-labeled radiopharmaceuticals by using standard radiopharmaceutical labeling approaches. 20 Boschi et al in 2003 suggested coordination sphere expansion from tetrahedral into square pyramidal or octahedral without changing the starting metal oxidation state by using weakly acidic oxalate ions (C 2 O 4 2-) to improve the RCP of the complex and radiochemical yield of final radiopharmaceutical. 21 Boschi et al in 2004 reported that the maximum volume up to 0.9 mL 188 Re activity can be added to the kit vial 1 to obtain the maximum radiochemical yield. For the same, the more concentrated activity was required to prepare sufficient patient dose of 188 Re-N-DEDC lipiodol, which was laborious and time-consuming process. 18 Thus, this study used improved DEDC kits   18 In our study, we assessed the post-labeling stability of 188 Re-N-DEDC complex up to 24 hours. The complex was almost stable till 1 hour with very less impact on RCP in 1 hour. The % RCP of complex was 90.83 AE 3.24% immediately after complex formation and then declined to 30.28 AE 4.54% in 24 hours (►Table 2). In practice, the lipiodol wase added to 188 Re-N-DEDC complex within 1 hour of formation.\\n\\nBoschi et al in 2004 in a preliminary clinical study in 12 patients with 188 Re-N-DEDC lipiodol reported excellent tumor uptake in the liver, without significant activity in the gut and kidneys, and no lung activity in 1 to 4 hours whole-body gamma imaging. At 20 hours whole-body imaging, the activity was retained in liver lesions with a minimal increase in colon and some uptake in the spleen and, on occasion, the bone marrow. All patients were evaluated to see any clinical and/or laboratory toxicities. Only one patient with portal vein thrombosis had grade 4 myelosuppression due to high dose of 188 Re-loaded lipiodol (6 Gbq). The patients with any hematological toxicity were recovered after platelet transfusion and granulocyte colony-stimulating factor therapy. Also, the patients with 188 Re-loaded lipiodol activities less than 6 GBq in three treatments over a period of 12 months manifested no deterioration in hematological or biochemical parameters. Finally, they decided to prescribe an upper limit of 5GBq of 188 Re-lipiodol activity in further clinical trials for intrahepatic arterial 188 Re-lipiodol therapy of unresectable HCC. 18 Our phase II clinical trial also showed almost similar results in human biodistribution study and clinical feasibility of intra-arterial therapy with 188 Re-N-DEDC lipiodol. The mean overall injected activity of 188 Re-N-DEDC lipiodol was less than 5 Gbq. Human biodistribution showed excellent 188 ReN-DEDC lipiodol retention inside the lesion up to 72 hours on planar and SPECT/CT imaging with mild lung uptake due to hepato-pulmonary shunt (< 10%). Both kid-neys were faintly visualized at 2 to 6 hours whole-body imaging with maximum uptake in 24 to 48 hours. The increased gut activity (small intestine) over time (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24) hours) was due to their lipophilic characteristic and slow elimination through hepatobiliary tract. High bladder uptake was due to urinary excretion as the main route (►Figs. 5 and 6). Also, toxicity was evaluated in all patients in median follow-up time up to 6 months. None of the patient had myelosuppression or any other long-term toxicity. Most of the patients had mild post-therapy clinical toxicities (nausea, vomiting, fever, abdominal pain) and were treated symptomatically. Patients with liver enzymes derangements were managed conservatively in hospital lasting for 3 days. Patients with hematological toxicities were treated accordingly with RBC transfusion or fresh frozen plasma infusion post-therapy whichever required (►Table 3).\\n\\nThakral et al in 2018 estimated the whole-body radiation exposure to radiopharmacist during synthesis of 188 Re-labeled radiopharmaceuticals. The radiation exposure to radiopharmacist during labeling of 188 Re-HDD lipiodol in mean time of 95 minutes was 52 µSv, 23 while our study estimated the mean whole body radiation dose of 9.8 AE 2.06 µSv during synthesis of 188 Re-N-DEDC lipiodol in a mean time of only 45 minutes using standard labeling method.\\n\\n\\nConclusion\\n\\nThis study reports a simple and user-friendly kit by addition of calculated amount of oxalic acid and disodium oxalate in improved DEDC kits which eliminated the need of glacial acetic acid for the preparation of 188 Re-N-DEDC lipiodol, a clinically established radiopharmaceutical for the treatment of inoperable HCC. This modification has led to a significant simplification of the procedure and required less synthesis time of 45 minutes and less whole-body radiation dose of 10 µSv during in-house synthesis of this therapeutic agent. Thus, the whole-body effective dose received by personnel involved was well within recommended safety levels of occupational dose limits of Atomic Energy Regulatory Board (AERB), India, that is, 20 mSv/year (averaged over 5 years); so, it can be concluded that manual synthesis of 188 Re-N-DEDC lipiodol is safe in radiation protection point of view. The biodistribution study showed excellent retention of activity in liver lesions and toxicity evaluation reported no long-term toxicity or myelosuppression to any patient. Thus, 188 Relipiodol, prepared with indigenous prepared DEDC kits, is clinically safe and effective therapy for the treatment of intermediate/advanced HCC when given through super selective tumor feeding artery.\\n\\n\\nAuthors' Contributions\\n\\nIn this study, seven authors have made their contributions and we hereby certify that there is a significant contribution by all the authors in the study as given below. Naresh Kumar helped in conception and designing of the study, labeling procedure, image acquisition, analysis and data interpretation, and drafting of the manuscript. Shamim Ahmed Shamim conceptualized and designed the study and wrote the manuscript. Priyanka Gupta helped in drafting of the manuscript and data interpretation. Viju Chirayil was involved in conceptualization and designing, and revising manuscript for important intellectual content. Suresh Subramanian and Madhava B. Mallia revised the manuscript for important intellectual content. Chandrasekhar Bal conceptualized and designed the study.\\n\\n\\nEthical Approval\\n\\nThe study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of All India Institute of Medical Sciences, New Delhi, India (IECPG-755/23.12.2021, RT-03/27.01.2022). All procedures performed in this study were in accordance with ethical standards of our institute.\\n\\nFig. 1\\n1Schematic diagram showing the reactions involving the preparation in Rhenium-188-N diethyldithiocarbamate ( 188 Re-N-DEDC) lipiodol. Step 1 involved the formation of 188 Re-N-DEDC complex following this step 2 involved addition of lipiodol and obtained final 188 Re-N-DEDC lipiodol.\\n\\nFig. 3\\n3Radiochromatograph plot to determine percentage of radiochemical purity (%RCP) of Rhenium-188-N diethyldithiocarbamate ( 188 Re-N-DEDC) complex (A) immediately after labeling having % RCP > 90% with R f ¼ 0.6 (B) at 24 hours after labeling having %RCP approximately 30%.\\n\\nFig. 2\\n2The trend of percentage of radiochemical purity (%RCP) and radiochemical yield (%RCY) with total number of labeling procedures. World Journal of Nuclear Medicine Vol. 22 No. 2/2023 © 2023. The Author(s).\\n\\nFig. 4\\n4The variation in percentage of radiochemical purity (%RCP) with time (hours) up to 24 hours indicated that the Rhenium-188-N diethyldithiocarbamate complex was almost stable till 1 hour with very less detectable change on % RCP.\\n\\nFig. 5\\n5A 52-year-old male with incidentally detected hepatitis B virus-related hepatocellular carcinoma with portal vein thrombosis underwent Rhenium-188-N diethyldithiocarbamate lipiodol transarterial radionuclide therapy; the post-therapy whole-body planar imaging up to 72 hours showing localized retention of lipiodol in liver seg. II/III lesion, faint visualization of kidneys in 2 to 6 hours with maximum visualization in 24 to 48 hours, minimal small intestine tracer uptake over 12 to 24 hours, and high bladder uptake due urinary excretion.\\n\\nFig. 7\\n7Co-registered single-photon emission computed tomography/computed tomography images of liver up to 72 hours of above-mentioned patient inFig. 5after transarterial administration of Rhenium-188-N diethyldithiocarbamate lipiodol, showing high retention of activity in seg II/ III lesion.\\n\\nFig. 8\\n8Co-registered single-photon emission computed tomography/computed tomography images of liver up to 72 hours of above-mentioned patient inFig. 6after transarterial administration of Rhenium-188-N diethyldithiocarbamate, showing high retention of activity in seg VI lesion.\\n\\n\\nstability of complex was decided by %RCP at room temperature that was 89.78 AE 3.67, 89.22 AE 3.77, 83.57 AE 3.2, 74.71 AE 5.18, 62.57 AE 3.20, 47 AE 4.43, and 30.28 AE 4.54 at 0.5, 1, 2, 3, 6, 12, and 24 hours, respectively. The variation of %RCP 188 Re-N-DEDC complex with time is given in ►Table 2 and ►Fig. 4. The mean overall %RCY of 188 Re-N-DEDC lipiodol was 86.04 AE 2.35% (►Table 1). In other eight samples, lipiodol (up to 4 mL) was added after Table 1 Results of all 18 labeling procedures performed for labeling of 188 Re-N-DEDC lipiodolS.no. \\n(labeling) \\n\\nActivity added \\n(mCi) \\n\\nActivity before \\nlipiodol addition \\n(mCi) \\n\\nFree activity \\n(mCi) \\n\\nLabeled lipiodol \\n(mCi) \\n\\n% RCY in \\nlipiodol phase \\n\\n%RCP of \\ncomplex \\n\\n1 \\n67 \\n65 \\n9 \\n56 \\n86 \\n96 \\n\\n2 \\n48 \\n47 \\n8.5 \\n38.5 \\n82 \\n86 \\n\\n3 \\n70 \\n69.5 \\n10 \\n59 \\n85 \\n90 \\n\\n4 \\n40 \\n40 \\n5 \\n35 \\n87 \\n94 \\n\\n5 \\n100 \\n99 \\n13.6 \\n85.4 \\n86.3 \\n91 \\n\\n6 \\n52 \\n51 \\n7 \\n44 \\n86 \\n89 \\n\\n7 \\n37 \\n36 \\n6.5 \\n29.5 \\n82 \\n87 \\n\\n8 \\n48 \\n47 \\n6 \\n41 \\n87 \\n94 \\n\\n9 \\n32 \\n31 \\n4.4 \\n26.6 \\n86 \\n95 \\n\\n10 \\n44 \\n44 \\n3.3 \\n40.7 \\n92.5 \\n91 \\n\\n11 \\n26 \\n25 \\n3 \\n22 \\n89 \\n87 \\n\\n12 \\n42 \\n41 \\n6.6 \\n34.4 \\n84 \\n91 \\n\\n13 \\n26 \\n25 \\n3.3 \\n21.7 \\n87 \\n86 \\n\\n14 \\n45 \\n45 \\n6 \\n39 \\n86 \\n91 \\n\\n15 \\n24 \\n23 \\n3.5 \\n19.5 \\n85 \\n89 \\n\\n16 \\n40 \\n39 \\n6 \\n33 \\n85 \\n89 \\n\\n17 \\n38 \\n38 \\n5 \\n33 \\n87 \\n95 \\n\\n18 \\n25 \\n24 \\n3.4 \\n20.6 \\n86 \\n94 \\n\\nAbbreviations: 188 Re-N-DEDC, Rhenium-188-N diethyldithiocarbamate; %RCP, percentage radiochemical purity; %RCY, percentage radiochemical yield. \\n\\nWorld Journal of Nuclear Medicine Vol. 22 No. 2/2023 © 2023. The Author(s). \\n24 hours incubation of 188 Re-N-DEDC complex (8 samples) \\nat room temperature. Mean %RCY in lipiodol phase with \\n188 Re-N-DEDC complex after 24 hours was 70.57 AE 3.69%. \\n\\nAlso, it was observed that there were no clear boundaries \\nbetween labeled lipiodol and free perrhenate phase after \\n24 hours, thus the separation of labeled lipiodol with \\n\\n188 Re-N-DEDC complex was not as clear as immediately \\n\\nafter labeling of 188 Re-N-DEDC complex. \\n\\nHuman Biodistribution and Feasibility of Study \\n\\nThirty-one (27 male, 4 female) patients with mean age of \\n55.9 AE 9.78 years of intermediate/advanced staged HCC \\npatients have been treated with 188 Re-N-DEDC lipiodol \\nTART. Overall mean injected activity of 188 Re-N-DEDC lip-\\niodol was 2.9 AE 0.9 GBq (78.4 AE 24.2 mCi). Their biodistribu-\\ntion showed localized retention of lipiodol inside the lesion \\nup to 72 hours on planar (►Figs. 5 and 6) and SPECT/CT \\n(►Figs. 7 and 8) imaging with only six patients (~19%) \\n\\n\\nTable 2\\n2Variation in %RCP of 188 Re-N-DEDC complex over timeTime after labeling (hours) \\n% RCP (mean AE SD) \\n\\n0 \\n90.81 AE 3.24 \\n\\n0.5 \\n89.78 AE 3.67 \\n\\n1 \\n89.22 AE 3.77 \\n\\n2 \\n83.57 AE 3.2 \\n\\n3 \\n74.71 AE 5.18 \\n\\n6 \\n62.57 AE 3.20 \\n\\n12 \\n47 AE 4.43 \\n\\n24 \\n30.28 AE 4.54 \\n\\nAbbreviations: 188 Re-N-DEDC, Rhenium-188-N diethyldithiocarbamate; \\n% RCP, percentage radiochemical purity; SD, standard deviation. \\n\\n\\n\\nTable 3\\n3Six sulphur, and DEDC labeled in lipiodol with 188 Re. The mean overall % RCY and % RCP using modified DEDC kits were 87.17% AE 2.7% and 95.43% AE 2.3%, respectively. Also, the modified DEDC kits had advantage of less preparation time and any volume of perrhenate activity that can be added to the kit vial. 22 This study also showed comparable results with improved DEDC kits having mean % RCY and % RCP of 86.04 AE 2.35% and 90.83 AE 3.24%, respectively. Boschi et al in 2004 reported an inevitable degradation of RCP over time due to radiolysis during preparation of 188 Re-N-DEDC lipiodol. The initial % RCP immediately after labeling was over 98% and declined to 50.2% over 24 hours.Patient characteristics, biodistribution, and toxicity \\nevaluation of patients after 188 Re-N-DEDC lipiodol \\nadministration \\n\\nPatient characteristics \\n\\nGender (n ¼ 31) \\nMale ¼ 27 \\nFemale ¼ 4 \\n\\nAge \\nMean ¼ 55.9 AE \\n9.78 years \\n\\nInjected activity \\nMean ¼ 2.9 AE 0.9 GBq \\n(78.4 AE 24.2 mCi) \\n\\nBiodistribution \\n\\nMild lung uptake \\nn ¼ 6 ($19%) \\n\\nMild thyroid uptake \\nn ¼ 5 ($16%) \\n\\nToxicity evaluation (CTCAE v5.0) \\n\\nGrade I derangement in AST/ALT \\n(> ULN-3.0 x ULN) \\n\\nn ¼ 20 (64.5%) \\n\\nGrade II derangement in AST/ALT \\n(> 3.0-5.0 x ULN) \\n\\nn ¼ 6 (19.3%) \\n\\nGrade III liver toxicity \\nn ¼ 1 \\n\\nHematological toxicity \\nGrade II \\nGrade III \\n\\nn ¼ 2 \\nn ¼ 2 \\n\\nAbbreviations: AST/ALT, aspartate aminotransferase/alanine amino-\\ntransferase; CTCAE v5.0, Common Terminology Criteria for Adverse \\nEvents version 5.0; 188 Re-N-DEDC, Rhenium-188-N diethyldithiocarba-\\nmate; ULN, upper limit of normal range. \\n\\nWorld Journal of Nuclear Medicine Vol. 22 No. 2/2023 © 2023. The Author(s).\\nClinical Feasibility and In Vivo Distribution of 188 Re-N-DEDC Lipiodol in HCC Patients Kumar et al.\\nWorld Journal of Nuclear Medicine Vol. 22 No. 2/2023 © 2023. The Author(s). Clinical Feasibility and In Vivo Distribution of 188 Re-N-DEDC Lipiodol in HCC Patients Kumar et al. 123\\nConflict of InterestNone declared.\\nThe evolving epidemiology of hepatocellular carcinoma: a global perspective. M C Wallace, D Preen, G P Jeffrey, L A Adams, Expert Rev Gastroenterol Hepatol. 906Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epide- miology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol 2015;9(06):765-779\\n\\nProfile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. S K Sarin, V Thakur, R C Guptan, J Gastroenterol Hepatol. 1606Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associ- ations. J Gastroenterol Hepatol 2001;16(06):666-673\\n\\nClinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. S B Paul, S B Chalamalasetty, S Vishnubhatla, Oncology. 773-4Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology 2009;77(3-4):162-171\\n\\nWorld Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. P Ferenci, M Fried, D Labrecque, J Gastrointestin Liver Dis. 1903World Gastroenterology Organisation Guidelines and Publications CommitteeFerenci P, Fried M, Labrecque D, et al; World Gastroenterology Organisation Guidelines and Publications Committee. World Gastroenterology Organisation Guideline. Hepatocellular carci- noma (HCC): a global perspective. J Gastrointestin Liver Dis 2010; 19(03):311-317\\n\\nGlobal Burden of Disease Liver Cancer Collaboration. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: results from the Global Burden of Disease Study. T Akinyemiju, S Abera, M Ahmed, JAMA Oncol. 312Akinyemiju T, Abera S, Ahmed M, et al; Global Burden of Disease Liver Cancer Collaboration. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: results from the Global Burden of Disease Study 2015. JAMA Oncol 2017;3 (12):1683-1691\\n\\nProjections of primary liver cancer to 2030 in 30 countries worldwide. P C Valery, M Laversanne, P J Clark, J L Petrick, K A Mcglynn, F Bray, Hepatology. 6702Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology 2018;67(02):600-611\\n\\nHeavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virusrelated cirrhosis. C W Lin, C C Lin, L R Mo, J Hepatol. 5804Lin CW, Lin CC, Mo LR, et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus- related cirrhosis. J Hepatol 2013;58(04):730-735\\n\\nPrognosis of hepatocellular carcinoma: the BCLC staging classification. J M Llovet, C Brú, J Bruix, Semin Liver Dis. 1903Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19(03): 329-338\\n\\nThe critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?. U Cillo, M Bassanello, A Vitale, J Hepatol. 4001Cillo U, Bassanello M, Vitale A, et al. The critical issue of hepato- cellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004;40(01):124-131\\n\\nValidation of the BCLC prognostic system in surgical hepatocellular cancer patients. A Vitale, E Saracino, P Boccagni, Transplant Proc. 4104Vitale A, Saracino E, Boccagni P, et al. Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. Transplant Proc 2009;41(04):1260-1263\\n\\nSHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. J M Llovet, S Ricci, V Mazzaferro, N Engl J Med. 35904Llovet JM, Ricci S, Mazzaferro V, et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359(04):378-390\\n\\nEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. A L Cheng, Y K Kang, Z Chen, Lancet Oncol. 1001Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-con- trolled trial. Lancet Oncol 2009;10(01):25-34\\n\\nInstitutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience. R Salem, A Gabr, A Riaz, Hepatology. 6804Salem R, Gabr A, Riaz A, et al. Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000- patient 15-year experience. Hepatology 2018;68(04):1429-1440\\n\\n131 I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases. S Jouneau, E Vauléon, S Caulet-Maugendre, Chest. 13906Jouneau S, Vauléon E, Caulet-Maugendre S, et al. 131 I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases. Chest 2011;139(06):1463-1469\\n\\nRhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives. N Lepareur, F Lacoeuille, C Bouvry, Doi:10.3389/fmed.2019.00132Front Med (Lausanne). 6132Lepareur N, Lacoeuille F, Bouvry C, et al. Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives. Front Med (Lausanne) 2019;6:132. Doi: 10.3389/fmed.2019.00132\\n\\nDevelopment of acetylated HDD kit for preparation of 188Re-HDD/lipiodol. Y S Lee, J M Jeong, Y J Kim, Appl Radiat Isot. 6501Lee YS, Jeong JM, Kim YJ, et al. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol. Appl Radiat Isot 2007;65 (01):64-69\\n\\nLipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model. J C Paeng, J M Jeong, C J Yoon, J Nucl Med. 4412Paeng JC, Jeong JM, Yoon CJ, et al. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model. J Nucl Med 2003;44(12):2033-2038\\n\\nA kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. A Boschi, L Uccelli, A Duatti, Doi:10.1097/01.mnm.0000130241.22068.4515208496Nucl Med Commun. 2507983Nucl Med CommunBoschi A, Uccelli L, Duatti A, et al. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and prelimi- nary therapeutic evaluation in patients with unresectable hepa- tocellular carcinoma. Nucl Med Commun 2004;25(07):691-699. Doi: 10.1097/01.mnm.0000130241.22068.45 Erratum in: Nucl Med Commun. 2004 Sep;25(9):983. PMID: 15208496\\n\\nImproved freeze-dried kit for the preparation of 188 ReN-DEDC/lipiodol for the therapy of unresectable hepatocellular carcinoma. M B Mallia, V Chirayil, A Dash, Appl Radiat Isot. 137Mallia MB, Chirayil V, Dash A. Improved freeze-dried kit for the preparation of 188 ReN-DEDC/lipiodol for the therapy of unresect- able hepatocellular carcinoma. Appl Radiat Isot 2018;137:147-153\\n\\nThe chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. E Deutsch, K Libson, J L Vanderheyden, A R Ketring, H R Maxon, Int J Rad Appl Instrum B. 1304Deutsch E, Libson K, Vanderheyden JL, Ketring AR, Maxon HR. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Int J Rad Appl Instrum B 1986;13(04):465-477\\n\\nHigh-yield synthesis of the terminal 188Re triple bond N multiple bond from generatorproduced [188ReO4](-). [188ReO4. A Boschi, C Bolzati, L Uccelli, A Duatti, Nucl Med Biol. 3004Boschi A, Bolzati C, Uccelli L, Duatti A. High-yield synthesis of the terminal 188Re triple bond N multiple bond from generator- produced [188ReO4](-). [188ReO4] Nucl Med Biol 2003;30(04): 381-387\\n\\nPreparation of rhenium-188-lipiodol using freeze-dried kits for transarterial radioembolization: an overview and experience in a hospital radiopharmacy. E R Radhakrishnan, V Chirayil, A Pandiyan, Cancer Biother Radiopharm. 3701Radhakrishnan ER, Chirayil V, Pandiyan A, et al. Preparation of rhenium-188-lipiodol using freeze-dried kits for transarterial radioembolization: an overview and experience in a hospital radiopharmacy. Cancer Biother Radiopharm 2022;37(01):63-70\\n\\nRadiation dose to the occupational worker during the synthesis of 188 Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department. Indian. P Thakral, Jyotsna, P Tandon, S Dureja, V Pant, I Sen, J Nucl Med. 3301Thakral P, Jyotsna,Tandon P, Dureja S, Pant V, Sen I. Radiation dose to the occupational worker during the synthesis of 188 Re-labeled Radiopharmaceuticals in the Nuclear Medicine Department. In- dian J Nucl Med 2018;33(01):1-5\\n\",\"annotations\":{\"abstract\":\"[{\\\"end\\\":4539,\\\"start\\\":2011},{\\\"end\\\":4539,\\\"start\\\":2011}]\",\"author\":\"[{\\\"end\\\":297,\\\"start\\\":189},{\\\"end\\\":408,\\\"start\\\":298},{\\\"end\\\":548,\\\"start\\\":409},{\\\"end\\\":740,\\\"start\\\":549},{\\\"end\\\":937,\\\"start\\\":741},{\\\"end\\\":1132,\\\"start\\\":938},{\\\"end\\\":1246,\\\"start\\\":1133},{\\\"end\\\":297,\\\"start\\\":189},{\\\"end\\\":408,\\\"start\\\":298},{\\\"end\\\":548,\\\"start\\\":409},{\\\"end\\\":740,\\\"start\\\":549},{\\\"end\\\":937,\\\"start\\\":741},{\\\"end\\\":1132,\\\"start\\\":938},{\\\"end\\\":1246,\\\"start\\\":1133}]\",\"authoraffiliation\":\"[{\\\"end\\\":296,\\\"start\\\":203},{\\\"end\\\":407,\\\"start\\\":314},{\\\"end\\\":547,\\\"start\\\":454},{\\\"end\\\":739,\\\"start\\\":564},{\\\"end\\\":936,\\\"start\\\":761},{\\\"end\\\":1131,\\\"start\\\":956},{\\\"end\\\":1245,\\\"start\\\":1152},{\\\"end\\\":296,\\\"start\\\":203},{\\\"end\\\":407,\\\"start\\\":314},{\\\"end\\\":547,\\\"start\\\":454},{\\\"end\\\":739,\\\"start\\\":564},{\\\"end\\\":936,\\\"start\\\":761},{\\\"end\\\":1131,\\\"start\\\":956},{\\\"end\\\":1245,\\\"start\\\":1152}]\",\"authorfirstname\":\"[{\\\"end\\\":195,\\\"start\\\":189},{\\\"end\\\":306,\\\"start\\\":298},{\\\"end\\\":415,\\\"start\\\":409},{\\\"end\\\":421,\\\"start\\\":416},{\\\"end\\\":553,\\\"start\\\":549},{\\\"end\\\":747,\\\"start\\\":741},{\\\"end\\\":945,\\\"start\\\":938},{\\\"end\\\":947,\\\"start\\\":946},{\\\"end\\\":1146,\\\"start\\\":1133},{\\\"end\\\":195,\\\"start\\\":189},{\\\"end\\\":306,\\\"start\\\":298},{\\\"end\\\":415,\\\"start\\\":409},{\\\"end\\\":421,\\\"start\\\":416},{\\\"end\\\":553,\\\"start\\\":549},{\\\"end\\\":747,\\\"start\\\":741},{\\\"end\\\":945,\\\"start\\\":938},{\\\"end\\\":947,\\\"start\\\":946},{\\\"end\\\":1146,\\\"start\\\":1133}]\",\"authorlastname\":\"[{\\\"end\\\":201,\\\"start\\\":196},{\\\"end\\\":312,\\\"start\\\":307},{\\\"end\\\":428,\\\"start\\\":422},{\\\"end\\\":562,\\\"start\\\":554},{\\\"end\\\":759,\\\"start\\\":748},{\\\"end\\\":954,\\\"start\\\":948},{\\\"end\\\":1150,\\\"start\\\":1147},{\\\"end\\\":201,\\\"start\\\":196},{\\\"end\\\":312,\\\"start\\\":307},{\\\"end\\\":428,\\\"start\\\":422},{\\\"end\\\":562,\\\"start\\\":554},{\\\"end\\\":759,\\\"start\\\":748},{\\\"end\\\":954,\\\"start\\\":948},{\\\"end\\\":1150,\\\"start\\\":1147}]\",\"bibauthor\":\"[{\\\"end\\\":34110,\\\"start\\\":34097},{\\\"end\\\":34119,\\\"start\\\":34110},{\\\"end\\\":34132,\\\"start\\\":34119},{\\\"end\\\":34143,\\\"start\\\":34132},{\\\"end\\\":34465,\\\"start\\\":34454},{\\\"end\\\":34475,\\\"start\\\":34465},{\\\"end\\\":34487,\\\"start\\\":34475},{\\\"end\\\":34838,\\\"start\\\":34828},{\\\"end\\\":34858,\\\"start\\\":34838},{\\\"end\\\":34874,\\\"start\\\":34858},{\\\"end\\\":35211,\\\"start\\\":35200},{\\\"end\\\":35220,\\\"start\\\":35211},{\\\"end\\\":35233,\\\"start\\\":35220},{\\\"end\\\":35845,\\\"start\\\":35831},{\\\"end\\\":35854,\\\"start\\\":35845},{\\\"end\\\":35863,\\\"start\\\":35854},{\\\"end\\\":36265,\\\"start\\\":36253},{\\\"end\\\":36279,\\\"start\\\":36265},{\\\"end\\\":36290,\\\"start\\\":36279},{\\\"end\\\":36303,\\\"start\\\":36290},{\\\"end\\\":36316,\\\"start\\\":36303},{\\\"end\\\":36324,\\\"start\\\":36316},{\\\"end\\\":36636,\\\"start\\\":36627},{\\\"end\\\":36645,\\\"start\\\":36636},{\\\"end\\\":36653,\\\"start\\\":36645},{\\\"end\\\":36932,\\\"start\\\":36920},{\\\"end\\\":36939,\\\"start\\\":36932},{\\\"end\\\":36948,\\\"start\\\":36939},{\\\"end\\\":37224,\\\"start\\\":37215},{\\\"end\\\":37238,\\\"start\\\":37224},{\\\"end\\\":37248,\\\"start\\\":37238},{\\\"end\\\":37539,\\\"start\\\":37529},{\\\"end\\\":37551,\\\"start\\\":37539},{\\\"end\\\":37563,\\\"start\\\":37551},{\\\"end\\\":37842,\\\"start\\\":37830},{\\\"end\\\":37851,\\\"start\\\":37842},{\\\"end\\\":37865,\\\"start\\\":37851},{\\\"end\\\":38228,\\\"start\\\":38217},{\\\"end\\\":38238,\\\"start\\\":38228},{\\\"end\\\":38246,\\\"start\\\":38238},{\\\"end\\\":38651,\\\"start\\\":38642},{\\\"end\\\":38659,\\\"start\\\":38651},{\\\"end\\\":38667,\\\"start\\\":38659},{\\\"end\\\":38972,\\\"start\\\":38961},{\\\"end\\\":38983,\\\"start\\\":38972},{\\\"end\\\":39003,\\\"start\\\":38983},{\\\"end\\\":39295,\\\"start\\\":39283},{\\\"end\\\":39309,\\\"start\\\":39295},{\\\"end\\\":39319,\\\"start\\\":39309},{\\\"end\\\":39672,\\\"start\\\":39663},{\\\"end\\\":39683,\\\"start\\\":39672},{\\\"end\\\":39692,\\\"start\\\":39683},{\\\"end\\\":40032,\\\"start\\\":40021},{\\\"end\\\":40043,\\\"start\\\":40032},{\\\"end\\\":40053,\\\"start\\\":40043},{\\\"end\\\":40485,\\\"start\\\":40475},{\\\"end\\\":40496,\\\"start\\\":40485},{\\\"end\\\":40506,\\\"start\\\":40496},{\\\"end\\\":41088,\\\"start\\\":41076},{\\\"end\\\":41100,\\\"start\\\":41088},{\\\"end\\\":41108,\\\"start\\\":41100},{\\\"end\\\":41477,\\\"start\\\":41466},{\\\"end\\\":41487,\\\"start\\\":41477},{\\\"end\\\":41505,\\\"start\\\":41487},{\\\"end\\\":41518,\\\"start\\\":41505},{\\\"end\\\":41529,\\\"start\\\":41518},{\\\"end\\\":41933,\\\"start\\\":41923},{\\\"end\\\":41944,\\\"start\\\":41933},{\\\"end\\\":41955,\\\"start\\\":41944},{\\\"end\\\":41965,\\\"start\\\":41955},{\\\"end\\\":42354,\\\"start\\\":42335},{\\\"end\\\":42366,\\\"start\\\":42354},{\\\"end\\\":42378,\\\"start\\\":42366},{\\\"end\\\":42813,\\\"start\\\":42802},{\\\"end\\\":42822,\\\"start\\\":42813},{\\\"end\\\":42832,\\\"start\\\":42822},{\\\"end\\\":42842,\\\"start\\\":42832},{\\\"end\\\":42850,\\\"start\\\":42842},{\\\"end\\\":42857,\\\"start\\\":42850},{\\\"end\\\":34110,\\\"start\\\":34097},{\\\"end\\\":34119,\\\"start\\\":34110},{\\\"end\\\":34132,\\\"start\\\":34119},{\\\"end\\\":34143,\\\"start\\\":34132},{\\\"end\\\":34465,\\\"start\\\":34454},{\\\"end\\\":34475,\\\"start\\\":34465},{\\\"end\\\":34487,\\\"start\\\":34475},{\\\"end\\\":34838,\\\"start\\\":34828},{\\\"end\\\":34858,\\\"start\\\":34838},{\\\"end\\\":34874,\\\"start\\\":34858},{\\\"end\\\":35211,\\\"start\\\":35200},{\\\"end\\\":35220,\\\"start\\\":35211},{\\\"end\\\":35233,\\\"start\\\":35220},{\\\"end\\\":35845,\\\"start\\\":35831},{\\\"end\\\":35854,\\\"start\\\":35845},{\\\"end\\\":35863,\\\"start\\\":35854},{\\\"end\\\":36265,\\\"start\\\":36253},{\\\"end\\\":36279,\\\"start\\\":36265},{\\\"end\\\":36290,\\\"start\\\":36279},{\\\"end\\\":36303,\\\"start\\\":36290},{\\\"end\\\":36316,\\\"start\\\":36303},{\\\"end\\\":36324,\\\"start\\\":36316},{\\\"end\\\":36636,\\\"start\\\":36627},{\\\"end\\\":36645,\\\"start\\\":36636},{\\\"end\\\":36653,\\\"start\\\":36645},{\\\"end\\\":36932,\\\"start\\\":36920},{\\\"end\\\":36939,\\\"start\\\":36932},{\\\"end\\\":36948,\\\"start\\\":36939},{\\\"end\\\":37224,\\\"start\\\":37215},{\\\"end\\\":37238,\\\"start\\\":37224},{\\\"end\\\":37248,\\\"start\\\":37238},{\\\"end\\\":37539,\\\"start\\\":37529},{\\\"end\\\":37551,\\\"start\\\":37539},{\\\"end\\\":37563,\\\"start\\\":37551},{\\\"end\\\":37842,\\\"start\\\":37830},{\\\"end\\\":37851,\\\"start\\\":37842},{\\\"end\\\":37865,\\\"start\\\":37851},{\\\"end\\\":38228,\\\"start\\\":38217},{\\\"end\\\":38238,\\\"start\\\":38228},{\\\"end\\\":38246,\\\"start\\\":38238},{\\\"end\\\":38651,\\\"start\\\":38642},{\\\"end\\\":38659,\\\"start\\\":38651},{\\\"end\\\":38667,\\\"start\\\":38659},{\\\"end\\\":38972,\\\"start\\\":38961},{\\\"end\\\":38983,\\\"start\\\":38972},{\\\"end\\\":39003,\\\"start\\\":38983},{\\\"end\\\":39295,\\\"start\\\":39283},{\\\"end\\\":39309,\\\"start\\\":39295},{\\\"end\\\":39319,\\\"start\\\":39309},{\\\"end\\\":39672,\\\"start\\\":39663},{\\\"end\\\":39683,\\\"start\\\":39672},{\\\"end\\\":39692,\\\"start\\\":39683},{\\\"end\\\":40032,\\\"start\\\":40021},{\\\"end\\\":40043,\\\"start\\\":40032},{\\\"end\\\":40053,\\\"start\\\":40043},{\\\"end\\\":40485,\\\"start\\\":40475},{\\\"end\\\":40496,\\\"start\\\":40485},{\\\"end\\\":40506,\\\"start\\\":40496},{\\\"end\\\":41088,\\\"start\\\":41076},{\\\"end\\\":41100,\\\"start\\\":41088},{\\\"end\\\":41108,\\\"start\\\":41100},{\\\"end\\\":41477,\\\"start\\\":41466},{\\\"end\\\":41487,\\\"start\\\":41477},{\\\"end\\\":41505,\\\"start\\\":41487},{\\\"end\\\":41518,\\\"start\\\":41505},{\\\"end\\\":41529,\\\"start\\\":41518},{\\\"end\\\":41933,\\\"start\\\":41923},{\\\"end\\\":41944,\\\"start\\\":41933},{\\\"end\\\":41955,\\\"start\\\":41944},{\\\"end\\\":41965,\\\"start\\\":41955},{\\\"end\\\":42354,\\\"start\\\":42335},{\\\"end\\\":42366,\\\"start\\\":42354},{\\\"end\\\":42378,\\\"start\\\":42366},{\\\"end\\\":42813,\\\"start\\\":42802},{\\\"end\\\":42822,\\\"start\\\":42813},{\\\"end\\\":42832,\\\"start\\\":42822},{\\\"end\\\":42842,\\\"start\\\":42832},{\\\"end\\\":42850,\\\"start\\\":42842},{\\\"end\\\":42857,\\\"start\\\":42850}]\",\"bibauthorfirstname\":\"[{\\\"end\\\":34098,\\\"start\\\":34097},{\\\"end\\\":34100,\\\"start\\\":34099},{\\\"end\\\":34111,\\\"start\\\":34110},{\\\"end\\\":34120,\\\"start\\\":34119},{\\\"end\\\":34122,\\\"start\\\":34121},{\\\"end\\\":34133,\\\"start\\\":34132},{\\\"end\\\":34135,\\\"start\\\":34134},{\\\"end\\\":34455,\\\"start\\\":34454},{\\\"end\\\":34457,\\\"start\\\":34456},{\\\"end\\\":34466,\\\"start\\\":34465},{\\\"end\\\":34476,\\\"start\\\":34475},{\\\"end\\\":34478,\\\"start\\\":34477},{\\\"end\\\":34829,\\\"start\\\":34828},{\\\"end\\\":34831,\\\"start\\\":34830},{\\\"end\\\":34839,\\\"start\\\":34838},{\\\"end\\\":34841,\\\"start\\\":34840},{\\\"end\\\":34859,\\\"start\\\":34858},{\\\"end\\\":35201,\\\"start\\\":35200},{\\\"end\\\":35212,\\\"start\\\":35211},{\\\"end\\\":35221,\\\"start\\\":35220},{\\\"end\\\":35832,\\\"start\\\":35831},{\\\"end\\\":35846,\\\"start\\\":35845},{\\\"end\\\":35855,\\\"start\\\":35854},{\\\"end\\\":36254,\\\"start\\\":36253},{\\\"end\\\":36256,\\\"start\\\":36255},{\\\"end\\\":36266,\\\"start\\\":36265},{\\\"end\\\":36280,\\\"start\\\":36279},{\\\"end\\\":36282,\\\"start\\\":36281},{\\\"end\\\":36291,\\\"start\\\":36290},{\\\"end\\\":36293,\\\"start\\\":36292},{\\\"end\\\":36304,\\\"start\\\":36303},{\\\"end\\\":36306,\\\"start\\\":36305},{\\\"end\\\":36317,\\\"start\\\":36316},{\\\"end\\\":36628,\\\"start\\\":36627},{\\\"end\\\":36630,\\\"start\\\":36629},{\\\"end\\\":36637,\\\"start\\\":36636},{\\\"end\\\":36639,\\\"start\\\":36638},{\\\"end\\\":36646,\\\"start\\\":36645},{\\\"end\\\":36648,\\\"start\\\":36647},{\\\"end\\\":36921,\\\"start\\\":36920},{\\\"end\\\":36923,\\\"start\\\":36922},{\\\"end\\\":36933,\\\"start\\\":36932},{\\\"end\\\":36940,\\\"start\\\":36939},{\\\"end\\\":37216,\\\"start\\\":37215},{\\\"end\\\":37225,\\\"start\\\":37224},{\\\"end\\\":37239,\\\"start\\\":37238},{\\\"end\\\":37530,\\\"start\\\":37529},{\\\"end\\\":37540,\\\"start\\\":37539},{\\\"end\\\":37552,\\\"start\\\":37551},{\\\"end\\\":37831,\\\"start\\\":37830},{\\\"end\\\":37833,\\\"start\\\":37832},{\\\"end\\\":37843,\\\"start\\\":37842},{\\\"end\\\":37852,\\\"start\\\":37851},{\\\"end\\\":38218,\\\"start\\\":38217},{\\\"end\\\":38220,\\\"start\\\":38219},{\\\"end\\\":38229,\\\"start\\\":38228},{\\\"end\\\":38231,\\\"start\\\":38230},{\\\"end\\\":38239,\\\"start\\\":38238},{\\\"end\\\":38643,\\\"start\\\":38642},{\\\"end\\\":38652,\\\"start\\\":38651},{\\\"end\\\":38660,\\\"start\\\":38659},{\\\"end\\\":38962,\\\"start\\\":38961},{\\\"end\\\":38973,\\\"start\\\":38972},{\\\"end\\\":38984,\\\"start\\\":38983},{\\\"end\\\":39284,\\\"start\\\":39283},{\\\"end\\\":39296,\\\"start\\\":39295},{\\\"end\\\":39310,\\\"start\\\":39309},{\\\"end\\\":39664,\\\"start\\\":39663},{\\\"end\\\":39666,\\\"start\\\":39665},{\\\"end\\\":39673,\\\"start\\\":39672},{\\\"end\\\":39675,\\\"start\\\":39674},{\\\"end\\\":39684,\\\"start\\\":39683},{\\\"end\\\":39686,\\\"start\\\":39685},{\\\"end\\\":40022,\\\"start\\\":40021},{\\\"end\\\":40024,\\\"start\\\":40023},{\\\"end\\\":40033,\\\"start\\\":40032},{\\\"end\\\":40035,\\\"start\\\":40034},{\\\"end\\\":40044,\\\"start\\\":40043},{\\\"end\\\":40046,\\\"start\\\":40045},{\\\"end\\\":40476,\\\"start\\\":40475},{\\\"end\\\":40486,\\\"start\\\":40485},{\\\"end\\\":40497,\\\"start\\\":40496},{\\\"end\\\":41077,\\\"start\\\":41076},{\\\"end\\\":41079,\\\"start\\\":41078},{\\\"end\\\":41089,\\\"start\\\":41088},{\\\"end\\\":41101,\\\"start\\\":41100},{\\\"end\\\":41467,\\\"start\\\":41466},{\\\"end\\\":41478,\\\"start\\\":41477},{\\\"end\\\":41488,\\\"start\\\":41487},{\\\"end\\\":41490,\\\"start\\\":41489},{\\\"end\\\":41506,\\\"start\\\":41505},{\\\"end\\\":41508,\\\"start\\\":41507},{\\\"end\\\":41519,\\\"start\\\":41518},{\\\"end\\\":41521,\\\"start\\\":41520},{\\\"end\\\":41924,\\\"start\\\":41923},{\\\"end\\\":41934,\\\"start\\\":41933},{\\\"end\\\":41945,\\\"start\\\":41944},{\\\"end\\\":41956,\\\"start\\\":41955},{\\\"end\\\":42336,\\\"start\\\":42335},{\\\"end\\\":42338,\\\"start\\\":42337},{\\\"end\\\":42355,\\\"start\\\":42354},{\\\"end\\\":42367,\\\"start\\\":42366},{\\\"end\\\":42803,\\\"start\\\":42802},{\\\"end\\\":42823,\\\"start\\\":42822},{\\\"end\\\":42833,\\\"start\\\":42832},{\\\"end\\\":42843,\\\"start\\\":42842},{\\\"end\\\":42851,\\\"start\\\":42850},{\\\"end\\\":34098,\\\"start\\\":34097},{\\\"end\\\":34100,\\\"start\\\":34099},{\\\"end\\\":34111,\\\"start\\\":34110},{\\\"end\\\":34120,\\\"start\\\":34119},{\\\"end\\\":34122,\\\"start\\\":34121},{\\\"end\\\":34133,\\\"start\\\":34132},{\\\"end\\\":34135,\\\"start\\\":34134},{\\\"end\\\":34455,\\\"start\\\":34454},{\\\"end\\\":34457,\\\"start\\\":34456},{\\\"end\\\":34466,\\\"start\\\":34465},{\\\"end\\\":34476,\\\"start\\\":34475},{\\\"end\\\":34478,\\\"start\\\":34477},{\\\"end\\\":34829,\\\"start\\\":34828},{\\\"end\\\":34831,\\\"start\\\":34830},{\\\"end\\\":34839,\\\"start\\\":34838},{\\\"end\\\":34841,\\\"start\\\":34840},{\\\"end\\\":34859,\\\"start\\\":34858},{\\\"end\\\":35201,\\\"start\\\":35200},{\\\"end\\\":35212,\\\"start\\\":35211},{\\\"end\\\":35221,\\\"start\\\":35220},{\\\"end\\\":35832,\\\"start\\\":35831},{\\\"end\\\":35846,\\\"start\\\":35845},{\\\"end\\\":35855,\\\"start\\\":35854},{\\\"end\\\":36254,\\\"start\\\":36253},{\\\"end\\\":36256,\\\"start\\\":36255},{\\\"end\\\":36266,\\\"start\\\":36265},{\\\"end\\\":36280,\\\"start\\\":36279},{\\\"end\\\":36282,\\\"start\\\":36281},{\\\"end\\\":36291,\\\"start\\\":36290},{\\\"end\\\":36293,\\\"start\\\":36292},{\\\"end\\\":36304,\\\"start\\\":36303},{\\\"end\\\":36306,\\\"start\\\":36305},{\\\"end\\\":36317,\\\"start\\\":36316},{\\\"end\\\":36628,\\\"start\\\":36627},{\\\"end\\\":36630,\\\"start\\\":36629},{\\\"end\\\":36637,\\\"start\\\":36636},{\\\"end\\\":36639,\\\"start\\\":36638},{\\\"end\\\":36646,\\\"start\\\":36645},{\\\"end\\\":36648,\\\"start\\\":36647},{\\\"end\\\":36921,\\\"start\\\":36920},{\\\"end\\\":36923,\\\"start\\\":36922},{\\\"end\\\":36933,\\\"start\\\":36932},{\\\"end\\\":36940,\\\"start\\\":36939},{\\\"end\\\":37216,\\\"start\\\":37215},{\\\"end\\\":37225,\\\"start\\\":37224},{\\\"end\\\":37239,\\\"start\\\":37238},{\\\"end\\\":37530,\\\"start\\\":37529},{\\\"end\\\":37540,\\\"start\\\":37539},{\\\"end\\\":37552,\\\"start\\\":37551},{\\\"end\\\":37831,\\\"start\\\":37830},{\\\"end\\\":37833,\\\"start\\\":37832},{\\\"end\\\":37843,\\\"start\\\":37842},{\\\"end\\\":37852,\\\"start\\\":37851},{\\\"end\\\":38218,\\\"start\\\":38217},{\\\"end\\\":38220,\\\"start\\\":38219},{\\\"end\\\":38229,\\\"start\\\":38228},{\\\"end\\\":38231,\\\"start\\\":38230},{\\\"end\\\":38239,\\\"start\\\":38238},{\\\"end\\\":38643,\\\"start\\\":38642},{\\\"end\\\":38652,\\\"start\\\":38651},{\\\"end\\\":38660,\\\"start\\\":38659},{\\\"end\\\":38962,\\\"start\\\":38961},{\\\"end\\\":38973,\\\"start\\\":38972},{\\\"end\\\":38984,\\\"start\\\":38983},{\\\"end\\\":39284,\\\"start\\\":39283},{\\\"end\\\":39296,\\\"start\\\":39295},{\\\"end\\\":39310,\\\"start\\\":39309},{\\\"end\\\":39664,\\\"start\\\":39663},{\\\"end\\\":39666,\\\"start\\\":39665},{\\\"end\\\":39673,\\\"start\\\":39672},{\\\"end\\\":39675,\\\"start\\\":39674},{\\\"end\\\":39684,\\\"start\\\":39683},{\\\"end\\\":39686,\\\"start\\\":39685},{\\\"end\\\":40022,\\\"start\\\":40021},{\\\"end\\\":40024,\\\"start\\\":40023},{\\\"end\\\":40033,\\\"start\\\":40032},{\\\"end\\\":40035,\\\"start\\\":40034},{\\\"end\\\":40044,\\\"start\\\":40043},{\\\"end\\\":40046,\\\"start\\\":40045},{\\\"end\\\":40476,\\\"start\\\":40475},{\\\"end\\\":40486,\\\"start\\\":40485},{\\\"end\\\":40497,\\\"start\\\":40496},{\\\"end\\\":41077,\\\"start\\\":41076},{\\\"end\\\":41079,\\\"start\\\":41078},{\\\"end\\\":41089,\\\"start\\\":41088},{\\\"end\\\":41101,\\\"start\\\":41100},{\\\"end\\\":41467,\\\"start\\\":41466},{\\\"end\\\":41478,\\\"start\\\":41477},{\\\"end\\\":41488,\\\"start\\\":41487},{\\\"end\\\":41490,\\\"start\\\":41489},{\\\"end\\\":41506,\\\"start\\\":41505},{\\\"end\\\":41508,\\\"start\\\":41507},{\\\"end\\\":41519,\\\"start\\\":41518},{\\\"end\\\":41521,\\\"start\\\":41520},{\\\"end\\\":41924,\\\"start\\\":41923},{\\\"end\\\":41934,\\\"start\\\":41933},{\\\"end\\\":41945,\\\"start\\\":41944},{\\\"end\\\":41956,\\\"start\\\":41955},{\\\"end\\\":42336,\\\"start\\\":42335},{\\\"end\\\":42338,\\\"start\\\":42337},{\\\"end\\\":42355,\\\"start\\\":42354},{\\\"end\\\":42367,\\\"start\\\":42366},{\\\"end\\\":42803,\\\"start\\\":42802},{\\\"end\\\":42823,\\\"start\\\":42822},{\\\"end\\\":42833,\\\"start\\\":42832},{\\\"end\\\":42843,\\\"start\\\":42842},{\\\"end\\\":42851,\\\"start\\\":42850}]\",\"bibauthorlastname\":\"[{\\\"end\\\":34108,\\\"start\\\":34101},{\\\"end\\\":34117,\\\"start\\\":34112},{\\\"end\\\":34130,\\\"start\\\":34123},{\\\"end\\\":34141,\\\"start\\\":34136},{\\\"end\\\":34463,\\\"start\\\":34458},{\\\"end\\\":34473,\\\"start\\\":34467},{\\\"end\\\":34485,\\\"start\\\":34479},{\\\"end\\\":34836,\\\"start\\\":34832},{\\\"end\\\":34856,\\\"start\\\":34842},{\\\"end\\\":34872,\\\"start\\\":34860},{\\\"end\\\":35209,\\\"start\\\":35202},{\\\"end\\\":35218,\\\"start\\\":35213},{\\\"end\\\":35231,\\\"start\\\":35222},{\\\"end\\\":35843,\\\"start\\\":35833},{\\\"end\\\":35852,\\\"start\\\":35847},{\\\"end\\\":35861,\\\"start\\\":35856},{\\\"end\\\":36263,\\\"start\\\":36257},{\\\"end\\\":36277,\\\"start\\\":36267},{\\\"end\\\":36288,\\\"start\\\":36283},{\\\"end\\\":36301,\\\"start\\\":36294},{\\\"end\\\":36314,\\\"start\\\":36307},{\\\"end\\\":36322,\\\"start\\\":36318},{\\\"end\\\":36634,\\\"start\\\":36631},{\\\"end\\\":36643,\\\"start\\\":36640},{\\\"end\\\":36651,\\\"start\\\":36649},{\\\"end\\\":36930,\\\"start\\\":36924},{\\\"end\\\":36937,\\\"start\\\":36934},{\\\"end\\\":36946,\\\"start\\\":36941},{\\\"end\\\":37222,\\\"start\\\":37217},{\\\"end\\\":37236,\\\"start\\\":37226},{\\\"end\\\":37246,\\\"start\\\":37240},{\\\"end\\\":37537,\\\"start\\\":37531},{\\\"end\\\":37549,\\\"start\\\":37541},{\\\"end\\\":37561,\\\"start\\\":37553},{\\\"end\\\":37840,\\\"start\\\":37834},{\\\"end\\\":37849,\\\"start\\\":37844},{\\\"end\\\":37863,\\\"start\\\":37853},{\\\"end\\\":38226,\\\"start\\\":38221},{\\\"end\\\":38236,\\\"start\\\":38232},{\\\"end\\\":38244,\\\"start\\\":38240},{\\\"end\\\":38649,\\\"start\\\":38644},{\\\"end\\\":38657,\\\"start\\\":38653},{\\\"end\\\":38665,\\\"start\\\":38661},{\\\"end\\\":38970,\\\"start\\\":38963},{\\\"end\\\":38981,\\\"start\\\":38974},{\\\"end\\\":39001,\\\"start\\\":38985},{\\\"end\\\":39293,\\\"start\\\":39285},{\\\"end\\\":39307,\\\"start\\\":39297},{\\\"end\\\":39317,\\\"start\\\":39311},{\\\"end\\\":39670,\\\"start\\\":39667},{\\\"end\\\":39681,\\\"start\\\":39676},{\\\"end\\\":39690,\\\"start\\\":39687},{\\\"end\\\":40030,\\\"start\\\":40025},{\\\"end\\\":40041,\\\"start\\\":40036},{\\\"end\\\":40051,\\\"start\\\":40047},{\\\"end\\\":40483,\\\"start\\\":40477},{\\\"end\\\":40494,\\\"start\\\":40487},{\\\"end\\\":40504,\\\"start\\\":40498},{\\\"end\\\":41086,\\\"start\\\":41080},{\\\"end\\\":41098,\\\"start\\\":41090},{\\\"end\\\":41106,\\\"start\\\":41102},{\\\"end\\\":41475,\\\"start\\\":41468},{\\\"end\\\":41485,\\\"start\\\":41479},{\\\"end\\\":41503,\\\"start\\\":41491},{\\\"end\\\":41516,\\\"start\\\":41509},{\\\"end\\\":41527,\\\"start\\\":41522},{\\\"end\\\":41931,\\\"start\\\":41925},{\\\"end\\\":41942,\\\"start\\\":41935},{\\\"end\\\":41953,\\\"start\\\":41946},{\\\"end\\\":41963,\\\"start\\\":41957},{\\\"end\\\":42352,\\\"start\\\":42339},{\\\"end\\\":42364,\\\"start\\\":42356},{\\\"end\\\":42376,\\\"start\\\":42368},{\\\"end\\\":42811,\\\"start\\\":42804},{\\\"end\\\":42820,\\\"start\\\":42813},{\\\"end\\\":42830,\\\"start\\\":42824},{\\\"end\\\":42840,\\\"start\\\":42834},{\\\"end\\\":42848,\\\"start\\\":42844},{\\\"end\\\":42855,\\\"start\\\":42852},{\\\"end\\\":34108,\\\"start\\\":34101},{\\\"end\\\":34117,\\\"start\\\":34112},{\\\"end\\\":34130,\\\"start\\\":34123},{\\\"end\\\":34141,\\\"start\\\":34136},{\\\"end\\\":34463,\\\"start\\\":34458},{\\\"end\\\":34473,\\\"start\\\":34467},{\\\"end\\\":34485,\\\"start\\\":34479},{\\\"end\\\":34836,\\\"start\\\":34832},{\\\"end\\\":34856,\\\"start\\\":34842},{\\\"end\\\":34872,\\\"start\\\":34860},{\\\"end\\\":35209,\\\"start\\\":35202},{\\\"end\\\":35218,\\\"start\\\":35213},{\\\"end\\\":35231,\\\"start\\\":35222},{\\\"end\\\":35843,\\\"start\\\":35833},{\\\"end\\\":35852,\\\"start\\\":35847},{\\\"end\\\":35861,\\\"start\\\":35856},{\\\"end\\\":36263,\\\"start\\\":36257},{\\\"end\\\":36277,\\\"start\\\":36267},{\\\"end\\\":36288,\\\"start\\\":36283},{\\\"end\\\":36301,\\\"start\\\":36294},{\\\"end\\\":36314,\\\"start\\\":36307},{\\\"end\\\":36322,\\\"start\\\":36318},{\\\"end\\\":36634,\\\"start\\\":36631},{\\\"end\\\":36643,\\\"start\\\":36640},{\\\"end\\\":36651,\\\"start\\\":36649},{\\\"end\\\":36930,\\\"start\\\":36924},{\\\"end\\\":36937,\\\"start\\\":36934},{\\\"end\\\":36946,\\\"start\\\":36941},{\\\"end\\\":37222,\\\"start\\\":37217},{\\\"end\\\":37236,\\\"start\\\":37226},{\\\"end\\\":37246,\\\"start\\\":37240},{\\\"end\\\":37537,\\\"start\\\":37531},{\\\"end\\\":37549,\\\"start\\\":37541},{\\\"end\\\":37561,\\\"start\\\":37553},{\\\"end\\\":37840,\\\"start\\\":37834},{\\\"end\\\":37849,\\\"start\\\":37844},{\\\"end\\\":37863,\\\"start\\\":37853},{\\\"end\\\":38226,\\\"start\\\":38221},{\\\"end\\\":38236,\\\"start\\\":38232},{\\\"end\\\":38244,\\\"start\\\":38240},{\\\"end\\\":38649,\\\"start\\\":38644},{\\\"end\\\":38657,\\\"start\\\":38653},{\\\"end\\\":38665,\\\"start\\\":38661},{\\\"end\\\":38970,\\\"start\\\":38963},{\\\"end\\\":38981,\\\"start\\\":38974},{\\\"end\\\":39001,\\\"start\\\":38985},{\\\"end\\\":39293,\\\"start\\\":39285},{\\\"end\\\":39307,\\\"start\\\":39297},{\\\"end\\\":39317,\\\"start\\\":39311},{\\\"end\\\":39670,\\\"start\\\":39667},{\\\"end\\\":39681,\\\"start\\\":39676},{\\\"end\\\":39690,\\\"start\\\":39687},{\\\"end\\\":40030,\\\"start\\\":40025},{\\\"end\\\":40041,\\\"start\\\":40036},{\\\"end\\\":40051,\\\"start\\\":40047},{\\\"end\\\":40483,\\\"start\\\":40477},{\\\"end\\\":40494,\\\"start\\\":40487},{\\\"end\\\":40504,\\\"start\\\":40498},{\\\"end\\\":41086,\\\"start\\\":41080},{\\\"end\\\":41098,\\\"start\\\":41090},{\\\"end\\\":41106,\\\"start\\\":41102},{\\\"end\\\":41475,\\\"start\\\":41468},{\\\"end\\\":41485,\\\"start\\\":41479},{\\\"end\\\":41503,\\\"start\\\":41491},{\\\"end\\\":41516,\\\"start\\\":41509},{\\\"end\\\":41527,\\\"start\\\":41522},{\\\"end\\\":41931,\\\"start\\\":41925},{\\\"end\\\":41942,\\\"start\\\":41935},{\\\"end\\\":41953,\\\"start\\\":41946},{\\\"end\\\":41963,\\\"start\\\":41957},{\\\"end\\\":42352,\\\"start\\\":42339},{\\\"end\\\":42364,\\\"start\\\":42356},{\\\"end\\\":42376,\\\"start\\\":42368},{\\\"end\\\":42811,\\\"start\\\":42804},{\\\"end\\\":42820,\\\"start\\\":42813},{\\\"end\\\":42830,\\\"start\\\":42824},{\\\"end\\\":42840,\\\"start\\\":42834},{\\\"end\\\":42848,\\\"start\\\":42844},{\\\"end\\\":42855,\\\"start\\\":42852}]\",\"bibentry\":\"[{\\\"attributes\\\":{\\\"id\\\":\\\"b0\\\",\\\"matched_paper_id\\\":12805560},\\\"end\\\":34353,\\\"start\\\":34020},{\\\"attributes\\\":{\\\"id\\\":\\\"b1\\\",\\\"matched_paper_id\\\":20565462},\\\"end\\\":34698,\\\"start\\\":34355},{\\\"attributes\\\":{\\\"id\\\":\\\"b2\\\",\\\"matched_paper_id\\\":9827456},\\\"end\\\":35097,\\\"start\\\":34700},{\\\"attributes\\\":{\\\"id\\\":\\\"b3\\\",\\\"matched_paper_id\\\":35744663},\\\"end\\\":35603,\\\"start\\\":35099},{\\\"attributes\\\":{\\\"id\\\":\\\"b4\\\"},\\\"end\\\":36180,\\\"start\\\":35605},{\\\"attributes\\\":{\\\"id\\\":\\\"b5\\\",\\\"matched_paper_id\\\":3686243},\\\"end\\\":36508,\\\"start\\\":36182},{\\\"attributes\\\":{\\\"id\\\":\\\"b6\\\",\\\"matched_paper_id\\\":19334932},\\\"end\\\":36846,\\\"start\\\":36510},{\\\"attributes\\\":{\\\"id\\\":\\\"b7\\\",\\\"matched_paper_id\\\":23889399},\\\"end\\\":37104,\\\"start\\\":36848},{\\\"attributes\\\":{\\\"id\\\":\\\"b8\\\",\\\"matched_paper_id\\\":40526924},\\\"end\\\":37442,\\\"start\\\":37106},{\\\"attributes\\\":{\\\"id\\\":\\\"b9\\\",\\\"matched_paper_id\\\":23280891},\\\"end\\\":37747,\\\"start\\\":37444},{\\\"attributes\\\":{\\\"id\\\":\\\"b10\\\"},\\\"end\\\":38039,\\\"start\\\":37749},{\\\"attributes\\\":{\\\"id\\\":\\\"b11\\\",\\\"matched_paper_id\\\":35610395},\\\"end\\\":38506,\\\"start\\\":38041},{\\\"attributes\\\":{\\\"id\\\":\\\"b12\\\",\\\"matched_paper_id\\\":205907841},\\\"end\\\":38882,\\\"start\\\":38508},{\\\"attributes\\\":{\\\"id\\\":\\\"b13\\\",\\\"matched_paper_id\\\":44201291},\\\"end\\\":39169,\\\"start\\\":38884},{\\\"attributes\\\":{\\\"doi\\\":\\\"Doi:10.3389/fmed.2019.00132\\\",\\\"id\\\":\\\"b14\\\",\\\"matched_paper_id\\\":189762916},\\\"end\\\":39588,\\\"start\\\":39171},{\\\"attributes\\\":{\\\"id\\\":\\\"b15\\\",\\\"matched_paper_id\\\":28180841},\\\"end\\\":39855,\\\"start\\\":39590},{\\\"attributes\\\":{\\\"id\\\":\\\"b16\\\",\\\"matched_paper_id\\\":23306197},\\\"end\\\":40301,\\\"start\\\":39857},{\\\"attributes\\\":{\\\"doi\\\":\\\"Doi:10.1097/01.mnm.0000130241.22068.45\\\",\\\"id\\\":\\\"b17\\\",\\\"matched_paper_id\\\":12936994},\\\"end\\\":40945,\\\"start\\\":40303},{\\\"attributes\\\":{\\\"id\\\":\\\"b18\\\",\\\"matched_paper_id\\\":4642176},\\\"end\\\":41324,\\\"start\\\":40947},{\\\"attributes\\\":{\\\"id\\\":\\\"b19\\\",\\\"matched_paper_id\\\":25203840},\\\"end\\\":41803,\\\"start\\\":41326},{\\\"attributes\\\":{\\\"id\\\":\\\"b20\\\"},\\\"end\\\":42180,\\\"start\\\":41805},{\\\"attributes\\\":{\\\"id\\\":\\\"b21\\\",\\\"matched_paper_id\\\":235377862},\\\"end\\\":42654,\\\"start\\\":42182},{\\\"attributes\\\":{\\\"id\\\":\\\"b22\\\",\\\"matched_paper_id\\\":23190373},\\\"end\\\":43100,\\\"start\\\":42656},{\\\"attributes\\\":{\\\"id\\\":\\\"b0\\\",\\\"matched_paper_id\\\":12805560},\\\"end\\\":34353,\\\"start\\\":34020},{\\\"attributes\\\":{\\\"id\\\":\\\"b1\\\",\\\"matched_paper_id\\\":20565462},\\\"end\\\":34698,\\\"start\\\":34355},{\\\"attributes\\\":{\\\"id\\\":\\\"b2\\\",\\\"matched_paper_id\\\":9827456},\\\"end\\\":35097,\\\"start\\\":34700},{\\\"attributes\\\":{\\\"id\\\":\\\"b3\\\",\\\"matched_paper_id\\\":35744663},\\\"end\\\":35603,\\\"start\\\":35099},{\\\"attributes\\\":{\\\"id\\\":\\\"b4\\\"},\\\"end\\\":36180,\\\"start\\\":35605},{\\\"attributes\\\":{\\\"id\\\":\\\"b5\\\",\\\"matched_paper_id\\\":3686243},\\\"end\\\":36508,\\\"start\\\":36182},{\\\"attributes\\\":{\\\"id\\\":\\\"b6\\\",\\\"matched_paper_id\\\":19334932},\\\"end\\\":36846,\\\"start\\\":36510},{\\\"attributes\\\":{\\\"id\\\":\\\"b7\\\",\\\"matched_paper_id\\\":23889399},\\\"end\\\":37104,\\\"start\\\":36848},{\\\"attributes\\\":{\\\"id\\\":\\\"b8\\\",\\\"matched_paper_id\\\":40526924},\\\"end\\\":37442,\\\"start\\\":37106},{\\\"attributes\\\":{\\\"id\\\":\\\"b9\\\",\\\"matched_paper_id\\\":23280891},\\\"end\\\":37747,\\\"start\\\":37444},{\\\"attributes\\\":{\\\"id\\\":\\\"b10\\\"},\\\"end\\\":38039,\\\"start\\\":37749},{\\\"attributes\\\":{\\\"id\\\":\\\"b11\\\",\\\"matched_paper_id\\\":35610395},\\\"end\\\":38506,\\\"start\\\":38041},{\\\"attributes\\\":{\\\"id\\\":\\\"b12\\\",\\\"matched_paper_id\\\":205907841},\\\"end\\\":38882,\\\"start\\\":38508},{\\\"attributes\\\":{\\\"id\\\":\\\"b13\\\",\\\"matched_paper_id\\\":44201291},\\\"end\\\":39169,\\\"start\\\":38884},{\\\"attributes\\\":{\\\"doi\\\":\\\"Doi:10.3389/fmed.2019.00132\\\",\\\"id\\\":\\\"b14\\\",\\\"matched_paper_id\\\":189762916},\\\"end\\\":39588,\\\"start\\\":39171},{\\\"attributes\\\":{\\\"id\\\":\\\"b15\\\",\\\"matched_paper_id\\\":28180841},\\\"end\\\":39855,\\\"start\\\":39590},{\\\"attributes\\\":{\\\"id\\\":\\\"b16\\\",\\\"matched_paper_id\\\":23306197},\\\"end\\\":40301,\\\"start\\\":39857},{\\\"attributes\\\":{\\\"doi\\\":\\\"Doi:10.1097/01.mnm.0000130241.22068.45\\\",\\\"id\\\":\\\"b17\\\",\\\"matched_paper_id\\\":12936994},\\\"end\\\":40945,\\\"start\\\":40303},{\\\"attributes\\\":{\\\"id\\\":\\\"b18\\\",\\\"matched_paper_id\\\":4642176},\\\"end\\\":41324,\\\"start\\\":40947},{\\\"attributes\\\":{\\\"id\\\":\\\"b19\\\",\\\"matched_paper_id\\\":25203840},\\\"end\\\":41803,\\\"start\\\":41326},{\\\"attributes\\\":{\\\"id\\\":\\\"b20\\\"},\\\"end\\\":42180,\\\"start\\\":41805},{\\\"attributes\\\":{\\\"id\\\":\\\"b21\\\",\\\"matched_paper_id\\\":235377862},\\\"end\\\":42654,\\\"start\\\":42182},{\\\"attributes\\\":{\\\"id\\\":\\\"b22\\\",\\\"matched_paper_id\\\":23190373},\\\"end\\\":43100,\\\"start\\\":42656}]\",\"bibref\":\"[{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b0\\\"},\\\"end\\\":4714,\\\"start\\\":4713},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b1\\\"},\\\"end\\\":4795,\\\"start\\\":4793},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b2\\\"},\\\"end\\\":4796,\\\"start\\\":4795},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b3\\\"},\\\"end\\\":5037,\\\"start\\\":5036},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b4\\\"},\\\"end\\\":5260,\\\"start\\\":5259},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b5\\\"},\\\"end\\\":5645,\\\"start\\\":5643},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b6\\\"},\\\"end\\\":5646,\\\"start\\\":5645},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b7\\\"},\\\"end\\\":6364,\\\"start\\\":6363},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b10\\\"},\\\"end\\\":6758,\\\"start\\\":6755},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b11\\\"},\\\"end\\\":6760,\\\"start\\\":6758},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b7\\\"},\\\"end\\\":6852,\\\"start\\\":6851},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b14\\\"},\\\"end\\\":7954,\\\"start\\\":7952},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":8112,\\\"start\\\":8110},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":8314,\\\"start\\\":8311},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b16\\\"},\\\"end\\\":8316,\\\"start\\\":8314},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":8783,\\\"start\\\":8781},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b18\\\"},\\\"end\\\":9424,\\\"start\\\":9422},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":14183,\\\"start\\\":14181},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":15986,\\\"start\\\":15983},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b18\\\"},\\\"end\\\":15988,\\\"start\\\":15986},{\\\"end\\\":19600,\\\"start\\\":19587},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b19\\\"},\\\"end\\\":20450,\\\"start\\\":20448},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b20\\\"},\\\"end\\\":20756,\\\"start\\\":20754},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":21084,\\\"start\\\":21082},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":21130,\\\"start\\\":21128},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":22687,\\\"start\\\":22685},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b11\\\"},\\\"end\\\":23311,\\\"start\\\":23307},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b12\\\"},\\\"end\\\":23315,\\\"start\\\":23311},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b13\\\"},\\\"end\\\":23319,\\\"start\\\":23315},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b14\\\"},\\\"end\\\":23323,\\\"start\\\":23319},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":23327,\\\"start\\\":23323},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b16\\\"},\\\"end\\\":23331,\\\"start\\\":23327},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":23335,\\\"start\\\":23331},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b18\\\"},\\\"end\\\":23339,\\\"start\\\":23335},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b19\\\"},\\\"end\\\":23343,\\\"start\\\":23339},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b20\\\"},\\\"end\\\":23347,\\\"start\\\":23343},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b21\\\"},\\\"end\\\":23351,\\\"start\\\":23347},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b22\\\"},\\\"end\\\":23355,\\\"start\\\":23351},{\\\"end\\\":23359,\\\"start\\\":23355},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b0\\\"},\\\"end\\\":4714,\\\"start\\\":4713},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b1\\\"},\\\"end\\\":4795,\\\"start\\\":4793},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b2\\\"},\\\"end\\\":4796,\\\"start\\\":4795},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b3\\\"},\\\"end\\\":5037,\\\"start\\\":5036},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b4\\\"},\\\"end\\\":5260,\\\"start\\\":5259},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b5\\\"},\\\"end\\\":5645,\\\"start\\\":5643},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b6\\\"},\\\"end\\\":5646,\\\"start\\\":5645},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b7\\\"},\\\"end\\\":6364,\\\"start\\\":6363},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b10\\\"},\\\"end\\\":6758,\\\"start\\\":6755},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b11\\\"},\\\"end\\\":6760,\\\"start\\\":6758},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b7\\\"},\\\"end\\\":6852,\\\"start\\\":6851},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b14\\\"},\\\"end\\\":7954,\\\"start\\\":7952},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":8112,\\\"start\\\":8110},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":8314,\\\"start\\\":8311},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b16\\\"},\\\"end\\\":8316,\\\"start\\\":8314},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":8783,\\\"start\\\":8781},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b18\\\"},\\\"end\\\":9424,\\\"start\\\":9422},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":14183,\\\"start\\\":14181},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":15986,\\\"start\\\":15983},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b18\\\"},\\\"end\\\":15988,\\\"start\\\":15986},{\\\"end\\\":19600,\\\"start\\\":19587},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b19\\\"},\\\"end\\\":20450,\\\"start\\\":20448},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b20\\\"},\\\"end\\\":20756,\\\"start\\\":20754},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":21084,\\\"start\\\":21082},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":21130,\\\"start\\\":21128},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":22687,\\\"start\\\":22685},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b11\\\"},\\\"end\\\":23311,\\\"start\\\":23307},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b12\\\"},\\\"end\\\":23315,\\\"start\\\":23311},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b13\\\"},\\\"end\\\":23319,\\\"start\\\":23315},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b14\\\"},\\\"end\\\":23323,\\\"start\\\":23319},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b15\\\"},\\\"end\\\":23327,\\\"start\\\":23323},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b16\\\"},\\\"end\\\":23331,\\\"start\\\":23327},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b17\\\"},\\\"end\\\":23335,\\\"start\\\":23331},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b18\\\"},\\\"end\\\":23339,\\\"start\\\":23335},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b19\\\"},\\\"end\\\":23343,\\\"start\\\":23339},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b20\\\"},\\\"end\\\":23347,\\\"start\\\":23343},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b21\\\"},\\\"end\\\":23351,\\\"start\\\":23347},{\\\"attributes\\\":{\\\"ref_id\\\":\\\"b22\\\"},\\\"end\\\":23355,\\\"start\\\":23351},{\\\"end\\\":23359,\\\"start\\\":23355}]\",\"bibtitle\":\"[{\\\"end\\\":34095,\\\"start\\\":34020},{\\\"end\\\":34452,\\\"start\\\":34355},{\\\"end\\\":34826,\\\"start\\\":34700},{\\\"end\\\":35198,\\\"start\\\":35099},{\\\"end\\\":35829,\\\"start\\\":35605},{\\\"end\\\":36251,\\\"start\\\":36182},{\\\"end\\\":36625,\\\"start\\\":36510},{\\\"end\\\":36918,\\\"start\\\":36848},{\\\"end\\\":37213,\\\"start\\\":37106},{\\\"end\\\":37527,\\\"start\\\":37444},{\\\"end\\\":37828,\\\"start\\\":37749},{\\\"end\\\":38215,\\\"start\\\":38041},{\\\"end\\\":38640,\\\"start\\\":38508},{\\\"end\\\":38959,\\\"start\\\":38884},{\\\"end\\\":39281,\\\"start\\\":39171},{\\\"end\\\":39661,\\\"start\\\":39590},{\\\"end\\\":40019,\\\"start\\\":39857},{\\\"end\\\":40473,\\\"start\\\":40303},{\\\"end\\\":41074,\\\"start\\\":40947},{\\\"end\\\":41464,\\\"start\\\":41326},{\\\"end\\\":41921,\\\"start\\\":41805},{\\\"end\\\":42333,\\\"start\\\":42182},{\\\"end\\\":42800,\\\"start\\\":42656},{\\\"end\\\":34095,\\\"start\\\":34020},{\\\"end\\\":34452,\\\"start\\\":34355},{\\\"end\\\":34826,\\\"start\\\":34700},{\\\"end\\\":35198,\\\"start\\\":35099},{\\\"end\\\":35829,\\\"start\\\":35605},{\\\"end\\\":36251,\\\"start\\\":36182},{\\\"end\\\":36625,\\\"start\\\":36510},{\\\"end\\\":36918,\\\"start\\\":36848},{\\\"end\\\":37213,\\\"start\\\":37106},{\\\"end\\\":37527,\\\"start\\\":37444},{\\\"end\\\":37828,\\\"start\\\":37749},{\\\"end\\\":38215,\\\"start\\\":38041},{\\\"end\\\":38640,\\\"start\\\":38508},{\\\"end\\\":38959,\\\"start\\\":38884},{\\\"end\\\":39281,\\\"start\\\":39171},{\\\"end\\\":39661,\\\"start\\\":39590},{\\\"end\\\":40019,\\\"start\\\":39857},{\\\"end\\\":40473,\\\"start\\\":40303},{\\\"end\\\":41074,\\\"start\\\":40947},{\\\"end\\\":41464,\\\"start\\\":41326},{\\\"end\\\":41921,\\\"start\\\":41805},{\\\"end\\\":42333,\\\"start\\\":42182},{\\\"end\\\":42800,\\\"start\\\":42656}]\",\"bibvenue\":\"[{\\\"end\\\":34175,\\\"start\\\":34143},{\\\"end\\\":34510,\\\"start\\\":34487},{\\\"end\\\":34882,\\\"start\\\":34874},{\\\"end\\\":35259,\\\"start\\\":35233},{\\\"end\\\":35873,\\\"start\\\":35863},{\\\"end\\\":36334,\\\"start\\\":36324},{\\\"end\\\":36662,\\\"start\\\":36653},{\\\"end\\\":36963,\\\"start\\\":36948},{\\\"end\\\":37257,\\\"start\\\":37248},{\\\"end\\\":37578,\\\"start\\\":37563},{\\\"end\\\":37877,\\\"start\\\":37865},{\\\"end\\\":38258,\\\"start\\\":38246},{\\\"end\\\":38677,\\\"start\\\":38667},{\\\"end\\\":39008,\\\"start\\\":39003},{\\\"end\\\":39366,\\\"start\\\":39346},{\\\"end\\\":39708,\\\"start\\\":39692},{\\\"end\\\":40063,\\\"start\\\":40053},{\\\"end\\\":40567,\\\"start\\\":40552},{\\\"end\\\":41124,\\\"start\\\":41108},{\\\"end\\\":41553,\\\"start\\\":41529},{\\\"end\\\":41978,\\\"start\\\":41965},{\\\"end\\\":42403,\\\"start\\\":42378},{\\\"end\\\":42867,\\\"start\\\":42857},{\\\"end\\\":34175,\\\"start\\\":34143},{\\\"end\\\":34510,\\\"start\\\":34487},{\\\"end\\\":34882,\\\"start\\\":34874},{\\\"end\\\":35259,\\\"start\\\":35233},{\\\"end\\\":35873,\\\"start\\\":35863},{\\\"end\\\":36334,\\\"start\\\":36324},{\\\"end\\\":36662,\\\"start\\\":36653},{\\\"end\\\":36963,\\\"start\\\":36948},{\\\"end\\\":37257,\\\"start\\\":37248},{\\\"end\\\":37578,\\\"start\\\":37563},{\\\"end\\\":37877,\\\"start\\\":37865},{\\\"end\\\":38258,\\\"start\\\":38246},{\\\"end\\\":38677,\\\"start\\\":38667},{\\\"end\\\":39008,\\\"start\\\":39003},{\\\"end\\\":39366,\\\"start\\\":39346},{\\\"end\\\":39708,\\\"start\\\":39692},{\\\"end\\\":40063,\\\"start\\\":40053},{\\\"end\\\":40567,\\\"start\\\":40552},{\\\"end\\\":41124,\\\"start\\\":41108},{\\\"end\\\":41553,\\\"start\\\":41529},{\\\"end\\\":41978,\\\"start\\\":41965},{\\\"end\\\":42403,\\\"start\\\":42378},{\\\"end\\\":42867,\\\"start\\\":42857}]\",\"figure\":\"[{\\\"attributes\\\":{\\\"id\\\":\\\"fig_0\\\"},\\\"end\\\":27320,\\\"start\\\":27029},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_1\\\"},\\\"end\\\":27600,\\\"start\\\":27321},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_2\\\"},\\\"end\\\":27813,\\\"start\\\":27601},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_3\\\"},\\\"end\\\":28051,\\\"start\\\":27814},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_4\\\"},\\\"end\\\":28603,\\\"start\\\":28052},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_5\\\"},\\\"end\\\":28898,\\\"start\\\":28604},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_6\\\"},\\\"end\\\":29179,\\\"start\\\":28899},{\\\"attributes\\\":{\\\"id\\\":\\\"tab_0\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":31640,\\\"start\\\":29180},{\\\"attributes\\\":{\\\"id\\\":\\\"tab_1\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":32040,\\\"start\\\":31641},{\\\"attributes\\\":{\\\"id\\\":\\\"tab_2\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":33626,\\\"start\\\":32041},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_0\\\"},\\\"end\\\":27320,\\\"start\\\":27029},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_1\\\"},\\\"end\\\":27600,\\\"start\\\":27321},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_2\\\"},\\\"end\\\":27813,\\\"start\\\":27601},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_3\\\"},\\\"end\\\":28051,\\\"start\\\":27814},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_4\\\"},\\\"end\\\":28603,\\\"start\\\":28052},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_5\\\"},\\\"end\\\":28898,\\\"start\\\":28604},{\\\"attributes\\\":{\\\"id\\\":\\\"fig_6\\\"},\\\"end\\\":29179,\\\"start\\\":28899},{\\\"attributes\\\":{\\\"id\\\":\\\"tab_0\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":31640,\\\"start\\\":29180},{\\\"attributes\\\":{\\\"id\\\":\\\"tab_1\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":32040,\\\"start\\\":31641},{\\\"attributes\\\":{\\\"id\\\":\\\"tab_2\\\",\\\"type\\\":\\\"table\\\"},\\\"end\\\":33626,\\\"start\\\":32041}]\",\"figurecaption\":\"[{\\\"end\\\":27320,\\\"start\\\":27038},{\\\"end\\\":27600,\\\"start\\\":27330},{\\\"end\\\":27813,\\\"start\\\":27610},{\\\"end\\\":28051,\\\"start\\\":27823},{\\\"end\\\":28603,\\\"start\\\":28061},{\\\"end\\\":28898,\\\"start\\\":28613},{\\\"end\\\":29179,\\\"start\\\":28908},{\\\"end\\\":29731,\\\"start\\\":29182},{\\\"end\\\":31703,\\\"start\\\":31651},{\\\"end\\\":32739,\\\"start\\\":32051},{\\\"end\\\":27320,\\\"start\\\":27038},{\\\"end\\\":27600,\\\"start\\\":27330},{\\\"end\\\":27813,\\\"start\\\":27610},{\\\"end\\\":28051,\\\"start\\\":27823},{\\\"end\\\":28603,\\\"start\\\":28061},{\\\"end\\\":28898,\\\"start\\\":28613},{\\\"end\\\":29179,\\\"start\\\":28908},{\\\"end\\\":29731,\\\"start\\\":29182},{\\\"end\\\":31703,\\\"start\\\":31651},{\\\"end\\\":32739,\\\"start\\\":32051}]\",\"figureref\":\"[{\\\"end\\\":19059,\\\"start\\\":19053},{\\\"end\\\":19059,\\\"start\\\":19053}]\",\"formula\":null,\"paragraph\":\"[{\\\"end\\\":9807,\\\"start\\\":4555},{\\\"end\\\":10272,\\\"start\\\":9886},{\\\"end\\\":10814,\\\"start\\\":10274},{\\\"end\\\":11893,\\\"start\\\":10816},{\\\"end\\\":12483,\\\"start\\\":11895},{\\\"end\\\":12932,\\\"start\\\":12485},{\\\"end\\\":13494,\\\"start\\\":12934},{\\\"end\\\":14949,\\\"start\\\":13545},{\\\"end\\\":15257,\\\"start\\\":14951},{\\\"end\\\":15419,\\\"start\\\":15280},{\\\"end\\\":15680,\\\"start\\\":15444},{\\\"end\\\":16312,\\\"start\\\":15741},{\\\"end\\\":16712,\\\"start\\\":16314},{\\\"end\\\":17770,\\\"start\\\":16714},{\\\"end\\\":18640,\\\"start\\\":17772},{\\\"end\\\":19767,\\\"start\\\":18642},{\\\"end\\\":20173,\\\"start\\\":19769},{\\\"end\\\":21533,\\\"start\\\":20188},{\\\"end\\\":24105,\\\"start\\\":21535},{\\\"end\\\":24560,\\\"start\\\":24107},{\\\"end\\\":25849,\\\"start\\\":24575},{\\\"end\\\":26653,\\\"start\\\":25876},{\\\"end\\\":27028,\\\"start\\\":26674},{\\\"end\\\":9807,\\\"start\\\":4555},{\\\"end\\\":10272,\\\"start\\\":9886},{\\\"end\\\":10814,\\\"start\\\":10274},{\\\"end\\\":11893,\\\"start\\\":10816},{\\\"end\\\":12483,\\\"start\\\":11895},{\\\"end\\\":12932,\\\"start\\\":12485},{\\\"end\\\":13494,\\\"start\\\":12934},{\\\"end\\\":14949,\\\"start\\\":13545},{\\\"end\\\":15257,\\\"start\\\":14951},{\\\"end\\\":15419,\\\"start\\\":15280},{\\\"end\\\":15680,\\\"start\\\":15444},{\\\"end\\\":16312,\\\"start\\\":15741},{\\\"end\\\":16712,\\\"start\\\":16314},{\\\"end\\\":17770,\\\"start\\\":16714},{\\\"end\\\":18640,\\\"start\\\":17772},{\\\"end\\\":19767,\\\"start\\\":18642},{\\\"end\\\":20173,\\\"start\\\":19769},{\\\"end\\\":21533,\\\"start\\\":20188},{\\\"end\\\":24105,\\\"start\\\":21535},{\\\"end\\\":24560,\\\"start\\\":24107},{\\\"end\\\":25849,\\\"start\\\":24575},{\\\"end\\\":26653,\\\"start\\\":25876},{\\\"end\\\":27028,\\\"start\\\":26674}]\",\"publisher\":null,\"sectionheader\":\"[{\\\"end\\\":4553,\\\"start\\\":4541},{\\\"end\\\":9831,\\\"start\\\":9810},{\\\"end\\\":9884,\\\"start\\\":9834},{\\\"end\\\":13543,\\\"start\\\":13497},{\\\"end\\\":15278,\\\"start\\\":15260},{\\\"end\\\":15442,\\\"start\\\":15422},{\\\"end\\\":15690,\\\"start\\\":15683},{\\\"end\\\":15739,\\\"start\\\":15693},{\\\"end\\\":20186,\\\"start\\\":20176},{\\\"end\\\":24573,\\\"start\\\":24563},{\\\"end\\\":25874,\\\"start\\\":25852},{\\\"end\\\":26672,\\\"start\\\":26656},{\\\"end\\\":27036,\\\"start\\\":27030},{\\\"end\\\":27328,\\\"start\\\":27322},{\\\"end\\\":27608,\\\"start\\\":27602},{\\\"end\\\":27821,\\\"start\\\":27815},{\\\"end\\\":28059,\\\"start\\\":28053},{\\\"end\\\":28611,\\\"start\\\":28605},{\\\"end\\\":28906,\\\"start\\\":28900},{\\\"end\\\":31649,\\\"start\\\":31642},{\\\"end\\\":32049,\\\"start\\\":32042},{\\\"end\\\":4553,\\\"start\\\":4541},{\\\"end\\\":9831,\\\"start\\\":9810},{\\\"end\\\":9884,\\\"start\\\":9834},{\\\"end\\\":13543,\\\"start\\\":13497},{\\\"end\\\":15278,\\\"start\\\":15260},{\\\"end\\\":15442,\\\"start\\\":15422},{\\\"end\\\":15690,\\\"start\\\":15683},{\\\"end\\\":15739,\\\"start\\\":15693},{\\\"end\\\":20186,\\\"start\\\":20176},{\\\"end\\\":24573,\\\"start\\\":24563},{\\\"end\\\":25874,\\\"start\\\":25852},{\\\"end\\\":26672,\\\"start\\\":26656},{\\\"end\\\":27036,\\\"start\\\":27030},{\\\"end\\\":27328,\\\"start\\\":27322},{\\\"end\\\":27608,\\\"start\\\":27602},{\\\"end\\\":27821,\\\"start\\\":27815},{\\\"end\\\":28059,\\\"start\\\":28053},{\\\"end\\\":28611,\\\"start\\\":28605},{\\\"end\\\":28906,\\\"start\\\":28900},{\\\"end\\\":31649,\\\"start\\\":31642},{\\\"end\\\":32049,\\\"start\\\":32042}]\",\"table\":\"[{\\\"end\\\":31640,\\\"start\\\":29731},{\\\"end\\\":32040,\\\"start\\\":31703},{\\\"end\\\":33626,\\\"start\\\":32739},{\\\"end\\\":31640,\\\"start\\\":29731},{\\\"end\\\":32040,\\\"start\\\":31703},{\\\"end\\\":33626,\\\"start\\\":32739}]\",\"tableref\":null,\"title\":\"[{\\\"end\\\":182,\\\"start\\\":1},{\\\"end\\\":1428,\\\"start\\\":1247},{\\\"end\\\":182,\\\"start\\\":1},{\\\"end\\\":1428,\\\"start\\\":1247}]\",\"venue\":\"[{\\\"end\\\":1443,\\\"start\\\":1430},{\\\"end\\\":1443,\\\"start\\\":1430}]\"}},\"updated\":\"2023-06-01T05:25:10Z\"}\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### Extract gz file information\n",
    "text = []\n",
    "with open(\"../mount-papers/fulltext/20230609_111759_00053_f77bs_0249e9d0-0537-4baa-bab3-78b0c18ce031\") as f:\n",
    "    for i in range(10,12):\n",
    "        print(f.readline(), end='\\n')\n",
    "#     all_text = f.readlines()\n",
    "#     all_text = json.loads(f.readlines())\n",
    "#     print(all_text)\n",
    "#     for lines in all_text:\n",
    "#         listed_line = list(lines)\n",
    "#         find_text = listed_line[\"text\"]\n",
    "#         print(listed_line)\n",
    "    f.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2d6d2f0e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "7fe463f6",
   "metadata": {},
   "source": [
    "## Model Testing"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "5a0f4c15",
   "metadata": {},
   "outputs": [],
   "source": [
    "max_sequence_length = 512\n",
    "embedding_size = 200"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "bec0ae4a",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'input_ids': [86, 17912, 13, 186, 203, 13, 161, 57, 3, 9, 16635, 13, 2371, 6, 3, 9, 964, 11, 650, 1068, 21, 889, 3867, 11, 758, 1502, 11, 3, 9, 1573, 12, 6570, 70, 1120, 2176, 2020, 12, 1195, 13, 796, 1308, 11, 4342, 3048, 3, 29748, 5, 1029, 23570, 12, 3, 5518, 7075, 12, 15971, 31, 7, 445, 5554, 489, 1808, 18189, 6, 132, 19, 150, 16316, 13, 2836, 13, 251, 1260, 796, 1308, 13, 1502, 11, 2443, 21, 889, 3867, 5, 1441, 3, 9, 484, 30, 889, 516, 758, 21, 105, 26, 30885, 153, 6315, 4837, 1688, 5, 3129, 26, 53, 190, 48, 251, 54, 1227, 19974, 8, 809, 13, 237, 8, 167, 1906, 889, 9739, 117, 8, 126, 4232, 131, 1119, 12, 105, 26, 32, 8, 269, 589, 153, 56, 1077, 428, 95, 6, 539, 3, 9, 1499, 6005, 11, 456, 3, 9886, 5, 100, 2136, 13, 12428, 11, 16538, 2361, 1550, 3, 9, 307, 194, 1587, 13834, 572, 6, 16, 17912, 13, 48, 508, 643, 13, 161, 6, 132, 3048, 224, 46, 3904, 27980, 16, 8, 1103, 11, 917, 13, 889, 3867, 7998, 59, 163, 45, 80, 1470, 12, 8, 416, 6, 68, 344, 1637, 441, 8, 337, 1470, 6, 42, 237, 344, 928, 5564, 16, 8, 337, 563, 55, 3, 28186, 44, 709, 8, 14311, 13, 125, 225, 36, 612, 11, 572, 273, 378, 225, 36, 612, 54, 36, 11770, 15, 26, 16, 705, 145, 3, 9, 3714, 18, 5120, 2908, 5, 290, 398, 36, 128, 19408, 5559, 24, 1340, 640, 14039, 11, 3735, 18, 9442, 2097, 6, 17067, 11, 20562, 2254, 6, 11, 3, 5518, 7075, 11, 15971, 2443, 5, 304, 3085, 7280, 889, 3867, 1502, 11, 6315, 11, 4234, 41, 232, 20459, 120, 61, 1581, 135, 6, 80, 398, 166, 734, 135, 44, 3, 9, 4431, 593, 11, 149, 79, 54, 1656, 8, 516, 5, 100, 1040, 56, 143, 46, 10246, 120, 8197, 11, 3, 115, 12380, 3332, 12, 13374, 34, 66, 323, 139, 424, 1321, 54, 734, 6, 8858, 3, 5490, 16, 3, 9, 4456, 2848, 3, 318, 3, 9, 686, 13, 6888, 190, 84, 1895, 2443, 54, 36, 72, 16447, 3, 4931, 5, 1], 'attention_mask': [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]}"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "T5tokens(text_example)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "46758dca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "BertModel(\n",
       "  (embeddings): BertEmbeddings(\n",
       "    (word_embeddings): Embedding(28996, 768, padding_idx=0)\n",
       "    (position_embeddings): Embedding(512, 768)\n",
       "    (token_type_embeddings): Embedding(2, 768)\n",
       "    (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "    (dropout): Dropout(p=0.1, inplace=False)\n",
       "  )\n",
       "  (encoder): BertEncoder(\n",
       "    (layer): ModuleList(\n",
       "      (0): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (1): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (2): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (3): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (4): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (5): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (6): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (7): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (8): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (9): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (10): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "      (11): BertLayer(\n",
       "        (attention): BertAttention(\n",
       "          (self): BertSelfAttention(\n",
       "            (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "          (output): BertSelfOutput(\n",
       "            (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "        (intermediate): BertIntermediate(\n",
       "          (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "          (intermediate_act_fn): GELUActivation()\n",
       "        )\n",
       "        (output): BertOutput(\n",
       "          (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "          (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "          (dropout): Dropout(p=0.1, inplace=False)\n",
       "        )\n",
       "      )\n",
       "    )\n",
       "  )\n",
       "  (pooler): BertPooler(\n",
       "    (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "    (activation): Tanh()\n",
       "  )\n",
       ")"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bio_bert_model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "cdf8655d",
   "metadata": {},
   "outputs": [],
   "source": [
    "### Instead of summarization can be used for classification of papers\n",
    "def biobert_classifier(embedding_size = 200, input_dimensions = 3, hidden_layers = 0, max_sequence_length = 512, learning_rate=0.01):\n",
    "  input_ids = tf.keras.layers.Input(shape=embedding_size, name=\"input_ids\")\n",
    "  token_type_ids = tf.keras.layers.Input(shape=embedding_size, name=\"token_type_id\")\n",
    "  attention_mask = tf.keras.layers.Input(shape=embedding_size, name=\"attention_mask\")\n",
    "\n",
    "  model_inputs = {\"input_ids\": input_ids,\n",
    "                  \"token_type_ids\": token_type_ids,\n",
    "                  \"attention_mask\": attention_mask}\n",
    "\n",
    "  embedding_matrix = tf.keras.layers.Embedding(200)\n",
    "\n",
    "  normalization_layer = tf.keras.layers.BatchNormalization()\n",
    "    \n",
    "  attention_layer = tf.keras.layers.Attention()\n",
    "\n",
    "  pooler_layer = bio_bert_model(model_inputs)[0]\n",
    "\n",
    "  dense_layer = tf.keras.layers.Dense(100, activation=\"relu\")(pooler_layer)\n",
    "\n",
    "  dropout_layer = tf.keras.layers.Dropout(0.3)(dense_layer)\n",
    "\n",
    "  final_layer = tf.keras.layers.Dense(1, activation=\"relu\")(dropout_layer)\n",
    "\n",
    "  classification_layer = tf.keras.layers.Dense(1, activation='sigmoid')(final_layer)\n",
    "\n",
    "  model = tf.keras.Model(inputs = [input_ids, token_type_ids, attention_mask], outputs = [classification_layer])\n",
    "\n",
    "  model.compile(optimizer=tf.keras.optimizers.Adam(learning_rate=learning_rate), \n",
    "                loss = tf.keras.losses.BinaryCrossentropy, \n",
    "                metrics = [tf.keras.metrics.Accuracy, tf.keras.metrics.Precision])\n",
    "  \n",
    "  return model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "1ff80d61",
   "metadata": {},
   "outputs": [],
   "source": [
    "summary_task_prefix = \"Summarize :\"\n",
    "qa_task_prefix = \"Question :\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "5a7bbdea",
   "metadata": {},
   "outputs": [],
   "source": [
    "### T5 Abstractive Text Summarization Model\n",
    "def t5summary_model(tokenizer, text, t5model):\n",
    "    summarize = \"summarize: \"\n",
    "    encoding = tokenizer([summarize+text], return_tensors='tf')\n",
    "    output = t5model.generate(encoding.input_ids,\n",
    "                             num_beams=3,\n",
    "                            no_repeat_ngram_size=2,\n",
    "                              top_k=10,\n",
    "                              top_p=80,\n",
    "                              max_length=50,\n",
    "                              min_length=30\n",
    "                             )\n",
    "    print([tokenizer.decode(w, skip_special_tokens=True, clean_up_tokenization_spaces=True) for w in output])\n",
    "#     print(summary)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "d5461b34",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<transformers.models.t5.modeling_tf_t5.TFT5ForConditionalGeneration at 0x7fb522033850>"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "T5Abstract_model"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "10b7d142",
   "metadata": {},
   "source": [
    "## Training New Models"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "5a913905",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting sacremoses\n",
      "  Downloading sacremoses-0.0.53.tar.gz (880 kB)\n",
      "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m880.6/880.6 kB\u001b[0m \u001b[31m11.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n",
      "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25hRequirement already satisfied: regex in /home/brathwaiten16_berkeley_edu/anaconda3/lib/python3.10/site-packages (from sacremoses) (2022.7.9)\n",
      "Requirement already satisfied: six in /home/brathwaiten16_berkeley_edu/anaconda3/lib/python3.10/site-packages (from sacremoses) (1.16.0)\n",
      "Requirement already satisfied: click in /home/brathwaiten16_berkeley_edu/anaconda3/lib/python3.10/site-packages (from sacremoses) (8.0.4)\n",
      "Requirement already satisfied: joblib in /home/brathwaiten16_berkeley_edu/anaconda3/lib/python3.10/site-packages (from sacremoses) (1.1.1)\n",
      "Requirement already satisfied: tqdm in /home/brathwaiten16_berkeley_edu/anaconda3/lib/python3.10/site-packages (from sacremoses) (4.64.1)\n",
      "Building wheels for collected packages: sacremoses\n",
      "  Building wheel for sacremoses (setup.py) ... \u001b[?25ldone\n",
      "\u001b[?25h  Created wheel for sacremoses: filename=sacremoses-0.0.53-py3-none-any.whl size=895241 sha256=282478fa0e8622b571e0e77f30ef2eb351f7ab7321eeb44d033344b4a8e0f9e9\n",
      "  Stored in directory: /home/brathwaiten16_berkeley_edu/.cache/pip/wheels/00/24/97/a2ea5324f36bc626e1ea0267f33db6aa80d157ee977e9e42fb\n",
      "Successfully built sacremoses\n",
      "Installing collected packages: sacremoses\n",
      "Successfully installed sacremoses-0.0.53\n"
     ]
    }
   ],
   "source": [
    "!pip install sacremoses"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "af9f9900",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "06ebc7da71ac47bcacdf51051610122c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Downloading pytorch_model.bin:   0%|          | 0.00/1.56G [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of the model checkpoint at microsoft/biogpt were not used when initializing BioGptModel: ['output_projection.weight']\n",
      "- This IS expected if you are initializing BioGptModel from the checkpoint of a model trained on another task or with another architecture (e.g. initializing a BertForSequenceClassification model from a BertForPreTraining model).\n",
      "- This IS NOT expected if you are initializing BioGptModel from the checkpoint of a model that you expect to be exactly identical (initializing a BertForSequenceClassification model from a BertForSequenceClassification model).\n"
     ]
    }
   ],
   "source": [
    "from transformers import BioGptModel, BioGptConfig, BioGptTokenizer\n",
    "biogpttokenizer = BioGptTokenizer.from_pretrained(\"microsoft/biogpt\")\n",
    "biogptmodel = BioGptModel.from_pretrained(\"microsoft/biogpt\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "18aecef7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['a clear and simple standard for software engineering and management requirements remains elusive. the paper will make an admittedly bold and brash attempt to boil it all down into something anyone can understand, hopefully resulting in an brief reference']\n"
     ]
    }
   ],
   "source": [
    "t5summary_model(T5tokens, text_example, T5Abstract_model)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "98e9f30c",
   "metadata": {},
   "source": [
    "### Q&A Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "190c1015",
   "metadata": {},
   "outputs": [],
   "source": [
    "### BioBERT or BERT Q&A or Clincal-T5-Large"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ecf4783a",
   "metadata": {},
   "source": [
    "### Extractive Summary Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b414ab51",
   "metadata": {},
   "outputs": [],
   "source": [
    "### T5 or T5v1 or Clincal-T5-Large or Bio-GPT"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da8c816c",
   "metadata": {},
   "source": [
    "### Classification Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "10eda67e",
   "metadata": {},
   "outputs": [],
   "source": [
    "### BERT or Bio-GPT"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "33841278",
   "metadata": {},
   "source": [
    "### NER Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "772b0ed7",
   "metadata": {},
   "outputs": [],
   "source": [
    "### BioELECTRA"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
